US171217A
(en)
|
|
1875-12-21 |
|
Improvement in convertible revolving harrows |
US506333A
(en)
|
|
1893-10-10 |
|
norwell |
NL6613143A
(zh)
|
1965-09-21 |
1967-03-22 |
|
|
US4177263A
(en)
|
1972-02-28 |
1979-12-04 |
Research Corporation |
Anti-animal tumor method
|
US5562925A
(en)
|
1970-04-20 |
1996-10-08 |
Research Corporation Tech. Inc. |
Anti-tumor method
|
CH605550A5
(zh)
|
1972-06-08 |
1978-09-29 |
Research Corp |
|
US3870719A
(en)
|
1972-06-16 |
1975-03-11 |
Us Health |
Synthesis of n-5-methyltetrahydrohomofolic acid and related reduced derivatives of homofolic acid
|
US3896111A
(en)
|
1973-02-20 |
1975-07-22 |
Research Corp |
Ansa macrolides
|
US4479957A
(en)
|
1973-04-02 |
1984-10-30 |
Eli Lilly And Company |
Use of vindesine in treating acute lymphatic leukemia and _other susceptible neoplasms
|
US3965254A
(en)
|
1973-05-23 |
1976-06-22 |
The Procter & Gamble Company |
Compositions for the treatment of calcific tumors
|
US3932417A
(en)
|
1973-10-24 |
1976-01-13 |
Eli Lilly And Company |
Dimeric indole alkaloid purification process
|
US3887565A
(en)
|
1974-05-06 |
1975-06-03 |
Lilly Co Eli |
Vincadioline
|
US4207416A
(en)
|
1974-09-05 |
1980-06-10 |
Engelhard Minerals & Chemicals Corporation |
Ethylenediamineplatinum(II) 2,4-dioxopyrimidine complexes
|
US3954773A
(en)
|
1974-11-21 |
1976-05-04 |
Eli Lilly And Company |
4-Desacetoxyvinblastine
|
US4079121A
(en)
|
1974-12-13 |
1978-03-14 |
Mobil Oil Corporation |
Complexes of beta platinum chloride and ammonia
|
FR2296418B1
(zh)
|
1974-12-30 |
1978-07-21 |
Anvar |
|
US3944554A
(en)
|
1975-01-09 |
1976-03-16 |
Eli Lilly And Company |
4-Desacetoxy-3-hydroxyvinblastine
|
JPS5198300A
(en)
|
1975-02-20 |
1976-08-30 |
|
Kanputoteshin oyobi sonoruijitaino seizoho
|
US4279817A
(en)
|
1975-05-30 |
1981-07-21 |
The United States Of America As Represented By The Department Of Health & Human Services |
Method for producing dimer alkaloids
|
US4029663A
(en)
|
1975-07-10 |
1977-06-14 |
Eli Lilly And Company |
Dimeric anhydro-vinca derivatives
|
HU172708B
(hu)
|
1975-10-28 |
1978-11-28 |
Richter Gedeon Vegyeszet |
Novyj sposob razdelenija diindolil-alkaloidov
|
US4255417A
(en)
|
1976-08-04 |
1981-03-10 |
Johnson Matthey, Inc. |
Platinum compounds for the irradication of skin blemishes
|
US4115418A
(en)
|
1976-09-02 |
1978-09-19 |
Government Of The United States Of America |
1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
|
JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
|
USRE30561E
(en)
|
1976-12-06 |
1981-03-31 |
Eli Lilly And Company |
Vinca alkaloid intermediates
|
USRE30560E
(en)
|
1976-12-06 |
1981-03-31 |
Eli Lilly And Company |
Oxazolidinedione derivatives of Vinca alkaloids
|
US4096148A
(en)
|
1976-12-06 |
1978-06-20 |
Eli Lilly And Company |
Oxazolidinedione derivatives of Vinca alkaloids
|
US4160767A
(en)
|
1976-12-06 |
1979-07-10 |
Eli Lilly And Company |
Vinca alkaloid intermediates
|
US4175133A
(en)
|
1977-02-18 |
1979-11-20 |
United States Of America |
1,2-Diaminocyclohexane platinum (II) complexes having antineoplastic activity against L1210 leukemia
|
US4162940A
(en)
|
1977-03-31 |
1979-07-31 |
Takeda Chemical Industries, Ltd. |
Method for producing Antibiotic C-15003 by culturing nocardia
|
US4151042A
(en)
|
1977-03-31 |
1979-04-24 |
Takeda Chemical Industries, Ltd. |
Method for producing maytansinol and its derivatives
|
US4278660A
(en)
|
1977-05-02 |
1981-07-14 |
Research Corporation |
Complex or salt of a platinum (II) compound and a nitrogen containing polymer
|
US4151185A
(en)
|
1977-05-02 |
1979-04-24 |
Research Corporation |
Complex or salt of a platinum (II) compound and a nitrogen containing polymer
|
HU178084B
(en)
|
1977-05-31 |
1982-03-28 |
Richter Gedeon Vegyeszet |
New process for the extraction of native vindoline,catharantine,3',4'-anhydrovinblastine,leurosine and,if desired,of other diinodle alkaloids from vinca rosea l.drogue
|
US4260609A
(en)
|
1977-06-01 |
1981-04-07 |
Merck & Co., Inc. |
Di- and tri- substituted thiazoles
|
US4419351A
(en)
|
1977-06-03 |
1983-12-06 |
Research Corporation |
Platinum-dioxopyrimidine complexes
|
US4137248A
(en)
|
1977-08-29 |
1979-01-30 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
|
JPS5829957B2
(ja)
|
1977-09-12 |
1983-06-25 |
喜徳 喜谷 |
新規な白金錯体
|
SE447902B
(sv)
|
1977-10-19 |
1986-12-22 |
Johnson Matthey Co Ltd |
Cis-koordinationsforening av platina och komposition innehallande foreningen
|
US4203912A
(en)
|
1977-10-19 |
1980-05-20 |
Johnson, Matthey & Co., Limited |
Compositions containing platinum
|
US4137230A
(en)
|
1977-11-14 |
1979-01-30 |
Takeda Chemical Industries, Ltd. |
Method for the production of maytansinoids
|
US4159269A
(en)
|
1978-03-03 |
1979-06-26 |
Eli Lilly And Company |
Preparation of oxazolidinedione derivatives of Vinca alkaloids
|
US4265814A
(en)
|
1978-03-24 |
1981-05-05 |
Takeda Chemical Industries |
Matansinol 3-n-hexadecanoate
|
US4307016A
(en)
|
1978-03-24 |
1981-12-22 |
Takeda Chemical Industries, Ltd. |
Demethyl maytansinoids
|
EP0004770B1
(en)
|
1978-04-11 |
1984-06-13 |
Efamol Limited |
Pharmaceutical and dietary composition comprising gamma-linolenic acids
|
SE7903361L
(sv)
|
1978-04-20 |
1979-10-21 |
Johnson Matthey Co Ltd |
Kompositioner innehallande platina
|
US4199504A
(en)
|
1978-05-15 |
1980-04-22 |
Eli Lilly And Company |
Bridged cathranthus alkaloid dimers
|
US4208414A
(en)
|
1978-06-05 |
1980-06-17 |
Eli Lilly And Company |
Vinblastine in rheumatoid arthritis
|
JPS6034958B2
(ja)
|
1978-09-02 |
1985-08-12 |
喜徳 喜谷 |
新規白金錯体
|
JPS5562090A
(en)
|
1978-10-27 |
1980-05-10 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
JPS55164687A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
US4256746A
(en)
|
1978-11-14 |
1981-03-17 |
Takeda Chemical Industries |
Dechloromaytansinoids, their pharmaceutical compositions and method of use
|
JPS5566585A
(en)
|
1978-11-14 |
1980-05-20 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
JPS55102583A
(en)
|
1979-01-31 |
1980-08-05 |
Takeda Chem Ind Ltd |
20-acyloxy-20-demethylmaytansinoid compound
|
US4234500A
(en)
|
1979-03-07 |
1980-11-18 |
Engelhard Minerals & Chemicals Corporation |
Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
|
US4234499A
(en)
|
1979-03-07 |
1980-11-18 |
Engelhard Minerals & Chemicals Corporation |
Cis-diammireplatinum(II) organophosphate complexes
|
US4291023A
(en)
|
1979-03-07 |
1981-09-22 |
Engelhard Minerals & Chemicals Corp. |
Method for treating tumors using cis-diammineplatinum (II) organophosphate complexes
|
US4248840A
(en)
|
1979-03-07 |
1981-02-03 |
Engelhard Minerals And Chemicals Corporation |
Cis-diammineplatinum(II) orthophosphate complexes
|
US4291027A
(en)
|
1979-03-07 |
1981-09-22 |
Engelhard Minerals & Chemicals Corp. |
Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
|
US4287187A
(en)
|
1979-03-07 |
1981-09-01 |
Engelhard Minerals & Chemicals Corporation |
Method for treating tumors with cis-diammineplatinum(II) orthophosphate complexes
|
JPS55162791A
(en)
|
1979-06-05 |
1980-12-18 |
Takeda Chem Ind Ltd |
Antibiotic c-15003pnd and its preparation
|
JPS55164685A
(en)
|
1979-06-08 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
JPS55164686A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
US4457926A
(en)
|
1979-06-20 |
1984-07-03 |
Engelhard Corporation |
Cis-Platinum(II) amine ascorbate complexes
|
US4462998A
(en)
|
1979-06-20 |
1984-07-31 |
Engelhard Corporation |
Method of using a cis-platinum(II) amine ascorbate
|
US4271085A
(en)
|
1979-06-20 |
1981-06-02 |
Engelhard Minerals & Chemicals Corporation |
Cis-platinum (II) amine lactate complexes
|
US4399282A
(en)
|
1979-07-10 |
1983-08-16 |
Kabushiki Kaisha Yakult Honsha |
Camptothecin derivatives
|
US4284579A
(en)
|
1979-07-17 |
1981-08-18 |
The United States Of America As Represented By The Of The Department Of Health & Human Services |
(N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
|
US4309428A
(en)
|
1979-07-30 |
1982-01-05 |
Takeda Chemical Industries, Ltd. |
Maytansinoids
|
US4273755A
(en)
|
1979-08-16 |
1981-06-16 |
Mpd Technology Corporation |
Preparation of platinum complexes
|
US4335087A
(en)
|
1979-08-16 |
1982-06-15 |
Mpd Technology Corporation |
Process for preparing cis-Pt(NH3)2 Cl2
|
GB2060615B
(en)
|
1979-08-23 |
1983-06-22 |
Johnson Matthey Co Ltd |
Platinum-amine complexes
|
JPS5645483A
(en)
|
1979-09-19 |
1981-04-25 |
Takeda Chem Ind Ltd |
C-15003phm and its preparation
|
EP0028683A1
(en)
|
1979-09-21 |
1981-05-20 |
Takeda Chemical Industries, Ltd. |
Antibiotic C-15003 PHO and production thereof
|
JPS5645485A
(en)
|
1979-09-21 |
1981-04-25 |
Takeda Chem Ind Ltd |
Production of c-15003pnd
|
US4302446A
(en)
|
1979-10-02 |
1981-11-24 |
Bristol-Myers Company |
Pharmaceutical compositions
|
NL181434C
(nl)
|
1980-01-03 |
1987-08-17 |
Tno |
Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
|
US4325950A
(en)
|
1980-02-19 |
1982-04-20 |
The Research Corporation Of The University Of Hawaii |
Platinum caffeine chloride anion complex and method
|
US4428943A
(en)
|
1980-06-09 |
1984-01-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
(N-Phosphonacetyl-L-aspartato) (1,2-diaminocyclohexane)platinum(II) or alkali metal salt
|
US4407300A
(en)
|
1980-07-14 |
1983-10-04 |
Davis Robert E |
Potentiometric diagnosis of cancer in vivo
|
US4581224A
(en)
|
1980-08-08 |
1986-04-08 |
Regents Of The University Of Minnesota |
Inhibition of undesired effect of platinum compounds
|
US4594238A
(en)
|
1980-08-08 |
1986-06-10 |
Regents Of University Of Minnesota |
Inhibition of undesired effect of platinum compounds
|
IL63658A0
(en)
|
1980-09-03 |
1981-11-30 |
Johnson Matthey Plc |
Co-ordination compound of platinum and its preparation
|
WO1982001188A1
(en)
|
1980-10-08 |
1982-04-15 |
Takeda Chemical Industries Ltd |
4,5-deoxymaytansinoide compounds and process for preparing same
|
HU183234B
(en)
|
1980-10-17 |
1984-04-28 |
Richter Gedeon Vegyeszet |
Process for the enantioselective synthesis of optically active cys-14-oxo-e-homo-eburnan
|
US4450254A
(en)
|
1980-11-03 |
1984-05-22 |
Standard Oil Company |
Impact improvement of high nitrile resins
|
US4399276A
(en)
|
1981-01-09 |
1983-08-16 |
Kabushiki Kaisha Yakult Honsha |
7-Substituted camptothecin derivatives
|
JPS57123198A
(en)
|
1981-01-23 |
1982-07-31 |
Shionogi & Co Ltd |
Novel platinum complex
|
US4315929A
(en)
|
1981-01-27 |
1982-02-16 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of controlling the European corn borer with trewiasine
|
US4313946A
(en)
|
1981-01-27 |
1982-02-02 |
The United States Of America As Represented By The Secretary Of Agriculture |
Chemotherapeutically active maytansinoids from Trewia nudiflora
|
US4563304A
(en)
|
1981-02-27 |
1986-01-07 |
Pharmacia Fine Chemicals Ab |
Pyridine compounds modifying proteins, polypeptides or polysaccharides
|
NL8101026A
(nl)
|
1981-03-03 |
1982-10-01 |
Tno |
Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel.
|
EP0062457B1
(en)
|
1981-04-02 |
1986-03-05 |
United Kingdom Atomic Energy Authority |
Improvements in or relating to the production of chemical compounds
|
US4375432A
(en)
|
1981-05-12 |
1983-03-01 |
Eli Lilly And Company |
Method of preparing vincristine
|
JPS57192389A
(en)
|
1981-05-20 |
1982-11-26 |
Takeda Chem Ind Ltd |
Novel maytansinoid
|
US4515954A
(en)
|
1981-08-24 |
1985-05-07 |
American Cyanamid Company |
Metal chelates of anthracene-9,10-bis-carbonylhydrazones
|
US4414205A
(en)
|
1981-08-28 |
1983-11-08 |
University Patents, Inc. |
Cell growth inhibitory substances
|
JPS5839685A
(ja)
|
1981-09-04 |
1983-03-08 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体及びその製造法
|
US4473692A
(en)
|
1981-09-04 |
1984-09-25 |
Kabushiki Kaisha Yakult Honsha |
Camptothecin derivatives and process for preparing same
|
US5108987A
(en)
|
1982-02-25 |
1992-04-28 |
Faulk Ward P |
Conjugates of proteins with anti-tumor agents
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
JPS58154582A
(ja)
|
1982-03-10 |
1983-09-14 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体およびその製造法
|
JPS58167592A
(ja)
|
1982-03-26 |
1983-10-03 |
Takeda Chem Ind Ltd |
新規メイタンシノイド化合物
|
US5087618A
(en)
|
1982-05-18 |
1992-02-11 |
University Of Florida |
Redox carriers for brain-specific drug delivery
|
LU84664A1
(fr)
|
1983-02-25 |
1984-11-08 |
Onmichem S A |
Alkyl-4-indolonaphtyridines et leur application therapeutique
|
US4486414A
(en)
|
1983-03-21 |
1984-12-04 |
Arizona Board Of Reagents |
Dolastatins A and B cell growth inhibitory substances
|
US4476026A
(en)
|
1983-03-21 |
1984-10-09 |
The Perkin-Elmer Corporation |
Apparatus useful in identifying a solute
|
USRE33071E
(en)
|
1983-03-28 |
1989-09-26 |
|
Platinum bound to transferrin for use in the treatment of breast tumors
|
US4906646A
(en)
|
1983-03-31 |
1990-03-06 |
Board Of Governors Of Wayne State University |
Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
|
US4720504A
(en)
|
1983-05-10 |
1988-01-19 |
Andrulis Research Corporation |
Use of bis-platinum complexes as antitumor agents
|
CA1237670A
(en)
|
1983-05-26 |
1988-06-07 |
Andrew S. Janoff |
Drug preparations of reduced toxicity
|
US5059591B1
(en)
|
1983-05-26 |
2000-04-25 |
Liposome Co Inc |
Drug preparations of reduced toxicity
|
JPS6019790A
(ja)
|
1983-07-14 |
1985-01-31 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体
|
JPS6032799A
(ja)
|
1983-07-29 |
1985-02-19 |
Microbial Chem Res Found |
新規4′−デメチル−4−エピポドフィロトキシン誘導体
|
US4544759A
(en)
|
1983-07-29 |
1985-10-01 |
American Cyanamid Company |
Platinum complexes of antitumor agents
|
US4550169A
(en)
|
1983-11-21 |
1985-10-29 |
American Cyanamid Company |
Platinum chelates of 2-hydrazino-azoles
|
US4567253A
(en)
|
1984-02-03 |
1986-01-28 |
Tony Durst |
2-Substituted derivatives of podophyllotoxin and etoposide
|
US4522750A
(en)
|
1984-02-21 |
1985-06-11 |
Eli Lilly And Company |
Cytotoxic compositions of transferrin coupled to vinca alkaloids
|
IL74449A
(en)
|
1984-03-01 |
1988-07-31 |
Us Commerce |
Tetrahalo-1,2-cyclohexane-diamino platinum complexes and anti-neoplastic compositions comprising them
|
US4562275A
(en)
|
1984-03-23 |
1985-12-31 |
Bristol-Myers Co. |
Antitumor platinum complexes
|
US4593034A
(en)
|
1984-04-06 |
1986-06-03 |
A. H. Robins Company, Inc. |
2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
|
US4843161A
(en)
|
1984-06-01 |
1989-06-27 |
Massachusetts Institute Of Technology |
Platinum-intercalative complexes for the treatment of cancer
|
GB8416048D0
(en)
|
1984-06-22 |
1984-07-25 |
Johnson Matthey Plc |
Anti-tumour compounds of platinum
|
EP0169645A1
(en)
|
1984-06-27 |
1986-01-29 |
Johnson Matthey Public Limited Company |
Platinum co-ordination compounds
|
US4952676A
(en)
|
1984-06-27 |
1990-08-28 |
Johnson Matthey Plc |
Monoclonal antibody-platinum co-ordination compound complex
|
US4956454A
(en)
|
1984-06-27 |
1990-09-11 |
Johnson Matthey Plc |
Monoclonal antibody - platinum co-ordination compound complex
|
ATE63919T1
(de)
|
1984-06-27 |
1991-06-15 |
Johnson Matthey Plc |
Platinkoordinationsverbindungen.
|
US4645661A
(en)
|
1984-06-29 |
1987-02-24 |
St. Jude Children's Research Hospital |
Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same
|
US4767611A
(en)
|
1984-07-03 |
1988-08-30 |
Gordon Robert T |
Method for affecting intracellular and extracellular electric and magnetic dipoles
|
HU193809B
(en)
|
1984-09-12 |
1987-12-28 |
Chugai Pharmaceutical Co Ltd |
Process for producing new platinum complexes
|
US4587331A
(en)
|
1984-12-17 |
1986-05-06 |
American Cyanamid Company |
Platinum complexes of polyhydroxylated alkylamines and 2-polyhydroxylated alkyl-1,2-diaminoethanes
|
US4665210A
(en)
|
1984-12-17 |
1987-05-12 |
American Cyanamid Company |
Platinum complexes of aliphatic tricarboxylic acids
|
US4739087A
(en)
|
1985-01-10 |
1988-04-19 |
Bristol-Myers Company |
Antineoplastic platinum complexes
|
JPS61227590A
(ja)
|
1985-04-02 |
1986-10-09 |
Microbial Chem Res Found |
新規4′−デメチル−4−エピポドフイロトキシン誘導体
|
US4728740A
(en)
|
1985-04-12 |
1988-03-01 |
Bristol-Myers Company |
Intermediates for the production of epipodophylotoxin and related compounds and processes for the preparation and use thereof
|
US4644072A
(en)
|
1985-04-12 |
1987-02-17 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US5011948A
(en)
|
1985-04-12 |
1991-04-30 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US5086182A
(en)
|
1985-04-12 |
1992-02-04 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US5120862A
(en)
|
1985-04-12 |
1992-06-09 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US4795819A
(en)
|
1985-04-12 |
1989-01-03 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US4866189A
(en)
|
1985-04-12 |
1989-09-12 |
Bristol-Myers Company |
Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
|
US4686104A
(en)
|
1985-04-30 |
1987-08-11 |
Sloan-Kettering Institute For Cancer Research |
Methods of treating bone disorders
|
US4895727A
(en)
|
1985-05-03 |
1990-01-23 |
Chemex Pharmaceuticals, Inc. |
Pharmaceutical vehicles for exhancing penetration and retention in the skin
|
US4667030A
(en)
|
1985-06-17 |
1987-05-19 |
Eli Lilly And Company |
Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
|
US5525338A
(en)
|
1992-08-21 |
1996-06-11 |
Immunomedics, Inc. |
Detection and therapy of lesions with biotin/avidin conjugates
|
US5776093A
(en)
|
1985-07-05 |
1998-07-07 |
Immunomedics, Inc. |
Method for imaging and treating organs and tissues
|
JPH0665648B2
(ja)
|
1985-09-25 |
1994-08-24 |
塩野義製薬株式会社 |
白金系抗癌物質の安定な凍結真空乾燥製剤
|
US5041581A
(en)
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
US5117022A
(en)
|
1985-10-18 |
1992-05-26 |
The Board Of Regents, The University Of Texas System |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
GB8525689D0
(en)
|
1985-10-18 |
1985-11-20 |
Johnson Mathey Plc |
Platinum coordination compounds
|
US5384127A
(en)
|
1985-10-18 |
1995-01-24 |
Board Of Regents, The University Of Texas System |
Stable liposomal formulations of lipophilic platinum compounds
|
CA1275922C
(en)
|
1985-11-28 |
1990-11-06 |
Harunobu Amagase |
Treatment of cancer
|
LU86212A1
(fr)
|
1985-12-16 |
1987-07-24 |
Omnichem Sa |
Nouveaux conjugues de la vinblastine et de ses derives,procede pour leur preparation et compositions pharmaceutiques les contenant
|
IL77334A
(en)
|
1985-12-16 |
1991-04-15 |
Univ Bar Ilan |
Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
|
EP0232693A3
(fr)
|
1985-12-16 |
1988-04-06 |
La Region Wallonne |
Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
|
US4970324A
(en)
|
1985-12-24 |
1990-11-13 |
Hoeschele James D |
Aminoalkyl-substituted azetidine platinum(II) complexes
|
US5116831A
(en)
|
1985-12-24 |
1992-05-26 |
Warner-Lambert Company |
Aminoalkyl-substituted cycloalkylamine platinum (II) complexes
|
JPH075608B2
(ja)
|
1986-01-13 |
1995-01-25 |
イ−ル−セルタ−ク ソシエテ アノニム |
ビンブラスチン誘導体
|
IL81264A
(en)
|
1986-01-30 |
1990-11-05 |
Takeda Chemical Industries Ltd |
Quinone derivatives,their production and pharmaceutical compositions containing them
|
US7838216B1
(en)
|
1986-03-05 |
2010-11-23 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Human gene related to but distinct from EGF receptor gene
|
US5395924A
(en)
|
1986-03-20 |
1995-03-07 |
Dana-Farber Cancer Institute, Inc. |
Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4765972A
(en)
|
1986-04-03 |
1988-08-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vinca alkaloid photoactive analogs and their uses
|
US5078137A
(en)
|
1986-05-05 |
1992-01-07 |
Massachusetts Institute Of Technology |
Apparatus for measuring oxygen partial pressure and temperature, in living tissue
|
US5100877A
(en)
|
1986-05-21 |
1992-03-31 |
Kuraray Co., Ltd. |
Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same
|
US4801688A
(en)
|
1986-05-27 |
1989-01-31 |
Eli Lilly And Company |
Hydrazone immunoglobulin conjugates
|
US5182368A
(en)
|
1986-06-13 |
1993-01-26 |
Ledbetter Jeffrey A |
Ligands and methods for augmenting B-cell proliferation
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
GB8620917D0
(en)
|
1986-08-29 |
1986-10-08 |
Davidson B C |
Platinum derivatives & cancer treatments
|
US5869620A
(en)
|
1986-09-02 |
1999-02-09 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
DE3762972D1
(de)
|
1986-10-03 |
1990-07-05 |
Asta Pharma Ag |
Diamin-platin (ii)-komplexverbindungen mit einem hydroxylierten 2-phenyl-indolring.
|
AU605512B2
(en)
|
1986-10-07 |
1991-01-17 |
Boehringer Mannheim Italia S.P.A. |
Pharmaceutical compositions having antineoplastic activity
|
US4906755A
(en)
|
1986-11-03 |
1990-03-06 |
Merrell Dow Pharmaceuticals Inc. |
Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
|
US5011959A
(en)
|
1986-11-17 |
1991-04-30 |
The Board Of Regents, The University Of Texas System |
1,2-diaminocyclohexane-platinum complexes with antitumor activity
|
US4968603A
(en)
|
1986-12-31 |
1990-11-06 |
The Regents Of The University Of California |
Determination of status in neoplastic disease
|
US4916217A
(en)
|
1987-01-08 |
1990-04-10 |
Bristol-Myers Company |
Phosphorus containing derivatives of epipodophyllotoxin
|
US5047528A
(en)
|
1987-01-22 |
1991-09-10 |
University Of Bristish Columbia |
Process of synthesis of vinblastine and vincristine
|
US5057302A
(en)
|
1987-02-13 |
1991-10-15 |
Abbott Laboratories |
Bifunctional chelating agents
|
US5256653A
(en)
|
1987-02-19 |
1993-10-26 |
Henkel Kommanditgesellschaft Auf Aktien |
Pharmaceutical preparations containing platinum complexes/phosphonic acid liquid and processes for their use
|
MX9203808A
(es)
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
CA1283904C
(en)
|
1987-03-06 |
1991-05-07 |
Mitsuaki Maeda |
Liposoluble platinum (ii) complex and preparation thereof
|
US5079600A
(en)
|
1987-03-06 |
1992-01-07 |
Schnur Joel M |
High resolution patterning on solid substrates
|
US5053512A
(en)
|
1987-04-14 |
1991-10-01 |
Research Triangle Institute |
Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
|
US5122526A
(en)
|
1987-03-31 |
1992-06-16 |
Research Triangle Institute |
Camptothecin and analogs thereof and pharmaceutical compositions and method using them
|
US5106742A
(en)
|
1987-03-31 |
1992-04-21 |
Wall Monroe E |
Camptothecin analogs as potent inhibitors of topoisomerase I
|
US5227380A
(en)
|
1987-03-31 |
1993-07-13 |
Research Triangle Institute |
Pharmaceutical compositions and methods employing camptothecins
|
US4894456A
(en)
|
1987-03-31 |
1990-01-16 |
Research Triangle Institute |
Synthesis of camptothecin and analogs thereof
|
US5244903A
(en)
|
1987-03-31 |
1993-09-14 |
Research Triangle Institute |
Camptothecin analogs as potent inhibitors of topoisomerase I
|
US5364858A
(en)
|
1987-03-31 |
1994-11-15 |
Research Triangle Institute |
Camptothecin analogs as potent inhibitors of topoisomerase I
|
US4981968A
(en)
|
1987-03-31 |
1991-01-01 |
Research Triangle Institute |
Synthesis of camptothecin and analogs thereof
|
US5026694A
(en)
|
1987-04-13 |
1991-06-25 |
The British Columbia Cancer Foundation |
Platinum complexes with one radiosensitizing ligand
|
US4921963A
(en)
|
1987-04-13 |
1990-05-01 |
British Columbia Cancer Foundation |
Platinum complexes with one radiosensitizing ligand
|
US5340817A
(en)
|
1987-04-14 |
1994-08-23 |
Research Triangle Institute |
Method of treating tumors with anti-tumor effective camptothecin compounds
|
US5180722A
(en)
|
1987-04-14 |
1993-01-19 |
Research Triangle Institute |
10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
|
US5122606A
(en)
|
1987-04-14 |
1992-06-16 |
Research Triangle Institute |
10,11-methylenedioxy camptothecins
|
US5049668A
(en)
|
1989-09-15 |
1991-09-17 |
Research Triangle Institute |
10,11-methylenedioxy-20(RS)-camptothecin analogs
|
DE3887194T2
(de)
|
1987-05-08 |
1994-07-28 |
Sankyo Co |
Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung.
|
US4853467A
(en)
|
1987-05-19 |
1989-08-01 |
Bristol-Myers Company |
Nitrogen containing derivatives of epipodophyllotoxin glucosides
|
US5811119A
(en)
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5010103A
(en)
|
1987-06-04 |
1991-04-23 |
The Research Foundation Of State University Of N.Y. |
Compositions and methods comprising 2-mercaptomethylglutaric acid derivatives
|
US4927966A
(en)
|
1987-06-04 |
1990-05-22 |
The Research Foundation Of State University Of New York |
2-mercaptomethylglutaric acid derivatives
|
US4939255A
(en)
|
1987-06-24 |
1990-07-03 |
Daiichi Pharmaceutical Co., Ltd. |
Hexa-cyclic camptothecin derivatives
|
CA1332413C
(en)
|
1987-06-25 |
1994-10-11 |
Kabushiki Kaisha Yakult Honsha |
Camptothecin derivatives and process for preparing same
|
US4874851A
(en)
|
1987-07-01 |
1989-10-17 |
Bristol-Meyers Company |
3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
|
US4816444A
(en)
|
1987-07-10 |
1989-03-28 |
Arizona Board Of Regents, Arizona State University |
Cell growth inhibitory substance
|
US5053226A
(en)
|
1987-07-15 |
1991-10-01 |
Board Of Regents, The University Of Texas System |
Monoclonal antibodies binding platinum complexes
|
US4895935A
(en)
|
1987-07-17 |
1990-01-23 |
Georgetown University |
Platinum pharmaceuticals
|
US4956459A
(en)
|
1987-07-17 |
1990-09-11 |
Georgetown University |
Platinum compounds suitable for use as pharmaceuticals
|
US4895936A
(en)
|
1987-07-17 |
1990-01-23 |
Georgetown University |
Platinum pharmaceuticals
|
US4904768A
(en)
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
ZA885929B
(en)
|
1987-08-25 |
1989-04-26 |
Oxi Gene Inc |
Agents for use in tumor or cancer cell killing therapy
|
US4888419A
(en)
|
1987-08-31 |
1989-12-19 |
Bristol-Myers Company |
3'-demethoxyepipodophyllotoxin glucoside derivatives
|
US4981979A
(en)
|
1987-09-10 |
1991-01-01 |
Neorx Corporation |
Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
|
US4943579A
(en)
|
1987-10-06 |
1990-07-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Water soluble prodrugs of camptothecin
|
FR2623504B1
(fr)
|
1987-11-25 |
1990-03-09 |
Adir |
Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
US5824311A
(en)
|
1987-11-30 |
1998-10-20 |
Trustees Of The University Of Pennsylvania |
Treatment of tumors with monoclonal antibodies against oncogene antigens
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
US4936465A
(en)
|
1987-12-07 |
1990-06-26 |
Zoeld Tibor |
Method and apparatus for fast, reliable, and environmentally safe dispensing of fluids, gases and individual particles of a suspension through pressure control at well defined parts of a closed flow-through system
|
US5378803A
(en)
|
1987-12-11 |
1995-01-03 |
Sterling Winthrop Inc. |
Azole-fused peptides and processes for preparation thereof
|
US4935504A
(en)
|
1987-12-18 |
1990-06-19 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-acyl derivatives
|
US5292497A
(en)
|
1987-12-22 |
1994-03-08 |
U.S. Bioscience, Inc. |
Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
US5720937A
(en)
|
1988-01-12 |
1998-02-24 |
Genentech, Inc. |
In vivo tumor detection assay
|
JPH0615547B2
(ja)
|
1988-01-20 |
1994-03-02 |
株式会社ヤクルト本社 |
新規なカンプトテシン誘導体
|
US4958010A
(en)
|
1988-02-16 |
1990-09-18 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside lactam derivatives
|
US5002755A
(en)
|
1988-02-18 |
1991-03-26 |
Vanderbilt University |
Method of controlling nephrotoxicity of anti-tumor plaintum compounds
|
US5011846A
(en)
|
1988-02-23 |
1991-04-30 |
Merrell Dow Pharmaceuticals Inc. |
Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
|
GB8806224D0
(en)
|
1988-03-16 |
1988-04-13 |
Johnson Matthey Plc |
Platinum chemotherapeutic product
|
NO169490C
(no)
|
1988-03-24 |
1992-07-01 |
Takeda Chemical Industries Ltd |
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
|
FR2629818B1
(fr)
|
1988-04-06 |
1990-11-16 |
Centre Nat Rech Scient |
Procede de preparation du taxol
|
USRE34277E
(en)
|
1988-04-06 |
1993-06-08 |
Centre National De La Recherche Scientifique |
Process for preparing taxol
|
FR2629819B1
(fr)
|
1988-04-06 |
1990-11-16 |
Rhone Poulenc Sante |
Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
|
US4923876A
(en)
|
1988-04-18 |
1990-05-08 |
Cetus Corporation |
Vinca alkaloid pharmaceutical compositions
|
GB8810173D0
(en)
|
1988-04-29 |
1988-06-02 |
Norsk Hydro As |
Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
|
DE68927479T2
(de)
|
1988-05-02 |
1997-04-03 |
Phanos Tech Inc |
Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
|
US4931553A
(en)
|
1988-05-11 |
1990-06-05 |
Gill Devinder S |
Platinum-polymer complexes and their use as antitumor agents
|
US4952408A
(en)
|
1988-05-23 |
1990-08-28 |
Georgetown University |
Liposome-encapsulated vinca alkaloids and their use in combatting tumors
|
US4946835A
(en)
|
1988-07-15 |
1990-08-07 |
Merck & Co., Inc. |
Antifungal fermentation product and method
|
US5084002A
(en)
|
1988-08-04 |
1992-01-28 |
Omnitron International, Inc. |
Ultra-thin high dose iridium source for remote afterloader
|
DE3827974A1
(de)
|
1988-08-18 |
1990-02-22 |
Boehringer Mannheim Gmbh |
Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
|
US4912204A
(en)
|
1988-09-06 |
1990-03-27 |
Bristol-Myers Company |
Fluoro-substituted epipodophyllotoxin glucosides
|
US5359047A
(en)
|
1988-09-22 |
1994-10-25 |
Massachusetts Institute Of Technology |
Nucleic acids encoding DNA structure-specific recognition protein and uses therefor
|
US5705334A
(en)
|
1988-09-22 |
1998-01-06 |
Massachusetts Institute Of Technology |
Uses for DNA structure-specific recognition protein
|
US5213788A
(en)
|
1988-09-29 |
1993-05-25 |
Ranney David F |
Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
|
US4912072A
(en)
|
1988-10-21 |
1990-03-27 |
Gas Research Institute |
Method for selective internal platinization of porous aluminosilicates
|
US5076973A
(en)
|
1988-10-24 |
1991-12-31 |
Arizona Board Of Regents |
Synthesis of dolastatin 3
|
US5434256A
(en)
|
1988-11-22 |
1995-07-18 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
US5393909A
(en)
|
1988-11-22 |
1995-02-28 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
US5041578A
(en)
|
1988-11-22 |
1991-08-20 |
Board Of Regents, The University Of Texas System |
Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
|
US5612019A
(en)
|
1988-12-19 |
1997-03-18 |
Gordon, Deceased; David |
Diagnosis and treatment of HIV viral infection using magnetic metal transferrin particles
|
US5242824A
(en)
|
1988-12-22 |
1993-09-07 |
Oncogen |
Monoclonal antibody to human carcinomas
|
US5217713A
(en)
|
1988-12-27 |
1993-06-08 |
Takeda Chemical Industries, Ltd. |
Cytotoxic bispecific monoclonal antibody, its production and use
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US4946954A
(en)
|
1989-01-17 |
1990-08-07 |
Georgetown University |
Platinum pharmaceutical agents
|
US4978744A
(en)
|
1989-01-27 |
1990-12-18 |
Arizona Board Of Regents |
Synthesis of dolastatin 10
|
WO1990008768A1
(en)
|
1989-02-01 |
1990-08-09 |
Institut Fizicheskoi Khimii Imeni L.V.Pisarzhevskogo Akademii Nauk Ukrainskoi Ssr |
Derivatives of platinum (p) with methyl silicone, method of obtaining them and antitumoral means based thereon
|
US5676978A
(en)
|
1989-02-14 |
1997-10-14 |
Amira, Inc. |
Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
|
US5300500A
(en)
|
1989-02-23 |
1994-04-05 |
The University Of North Carolina At Chapel Hill |
4 beta-amino podophyllotoxin analog compounds and methods
|
US4985416A
(en)
|
1989-03-13 |
1991-01-15 |
Dana Farber Cancer Institute, Inc. |
Platinum complexes of azodiazonium dyes as anti-tumor agents
|
US5019504A
(en)
|
1989-03-23 |
1991-05-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Production of taxol or taxol-like compounds in cell culture
|
US5004593A
(en)
|
1989-04-17 |
1991-04-02 |
Mayo Foundation For Medical Education And Research |
Hexamethylmelamine formulation exhibiting reduced neurotoxicity
|
IT1230145B
(it)
|
1989-05-05 |
1991-10-14 |
Boehringer Biochemia Srl |
Complessi di rutenio (iii) come agenti antineoplastici.
|
US5162115A
(en)
|
1989-05-09 |
1992-11-10 |
Pietronigro Dennis D |
Antineoplastic solution and method for treating neoplasms
|
US4879278A
(en)
|
1989-05-16 |
1989-11-07 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
|
US4986988A
(en)
|
1989-05-18 |
1991-01-22 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13
|
US4965348A
(en)
|
1989-05-19 |
1990-10-23 |
Bristol-Myers Company |
Dimeric epipodophyllotoxin glucoside derivatives
|
US5175315A
(en)
|
1989-05-31 |
1992-12-29 |
Florida State University |
Method for preparation of taxol using β-lactam
|
MY110249A
(en)
|
1989-05-31 |
1998-03-31 |
Univ Florida State |
Method for preparation of taxol using beta lactam
|
US4994591A
(en)
|
1989-06-02 |
1991-02-19 |
The Research Foundation Of State University Of Ny |
Platinum complexes derived from b-silyamines
|
US5036055A
(en)
|
1989-06-07 |
1991-07-30 |
Bristol-Myers Company |
Acylated derivatives of etoposide
|
GB8914040D0
(en)
|
1989-06-19 |
1989-08-09 |
Wellcome Found |
Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
|
GB8914060D0
(en)
|
1989-06-19 |
1989-08-09 |
Wellcome Found |
Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
|
US5208238A
(en)
|
1989-06-19 |
1993-05-04 |
Burroughs Wellcome Company |
Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
|
GB8914061D0
(en)
|
1989-06-19 |
1989-08-09 |
Wellcome Found |
Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
|
US5705157A
(en)
|
1989-07-27 |
1998-01-06 |
The Trustees Of The University Of Pennsylvania |
Methods of treating cancerous cells with anti-receptor antibodies
|
FR2651348B1
(zh)
|
1989-08-04 |
1993-01-22 |
Adir |
|
US5460785A
(en)
|
1989-08-09 |
1995-10-24 |
Rhomed Incorporated |
Direct labeling of antibodies and other protein with metal ions
|
US5443816A
(en)
|
1990-08-08 |
1995-08-22 |
Rhomed Incorporated |
Peptide-metal ion pharmaceutical preparation and method
|
US5066645A
(en)
|
1989-09-01 |
1991-11-19 |
Bristol-Myers Company |
Epipodophyllotoxin altroside derivatives
|
EP0418099B1
(en)
|
1989-09-15 |
2001-12-19 |
Research Triangle Institute |
Process of preparation of 10, 11-Methylenedioxy-20 (RS) camptothecin and 10, 11-methylenedioxy-20 (S) - camptothecin analog
|
CA2026147C
(en)
*
|
1989-10-25 |
2006-02-07 |
Ravi J. Chari |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5552154A
(en)
|
1989-11-06 |
1996-09-03 |
The Stehlin Foundation For Cancer Research |
Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
|
HU204995B
(en)
|
1989-11-07 |
1992-03-30 |
Richter Gedeon Vegyeszet |
Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
|
US5138036A
(en)
|
1989-11-13 |
1992-08-11 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
|
US5015744A
(en)
|
1989-11-14 |
1991-05-14 |
Florida State University |
Method for preparation of taxol using an oxazinone
|
US5136060A
(en)
|
1989-11-14 |
1992-08-04 |
Florida State University |
Method for preparation of taxol using an oxazinone
|
US5034380A
(en)
|
1989-11-20 |
1991-07-23 |
Bristol-Myers Squibb Company |
Alkoxymethylidene epipodophyllotoxin glucosides
|
US5258376A
(en)
|
1989-11-22 |
1993-11-02 |
Bernstein Lawrence R |
Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
JPH0776229B2
(ja)
|
1989-12-12 |
1995-08-16 |
東レ株式会社 |
新規白金(2)錯体および悪性腫瘍治療剤
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
KR910014122A
(ko)
|
1990-01-19 |
1991-08-31 |
디께다 가즈히꼬 |
에토포시드-2-디메틸아미노 화합물의 동결건조 제제
|
US5028726A
(en)
|
1990-02-07 |
1991-07-02 |
The University Of Vermont And State Agricultural College |
Platinum amine sulfoxide complexes
|
US5238955A
(en)
|
1990-04-10 |
1993-08-24 |
Asta Pharma Ag |
Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkylethylenediamines
|
WO1991015124A1
(en)
|
1990-04-10 |
1991-10-17 |
The University Of Vermont |
Modulator agent and use thereof
|
US5081234A
(en)
|
1990-04-30 |
1992-01-14 |
Bristol-Myers Squibb Co. |
4'-demethylepipodophyllotoxin glycosides
|
FR2662440B1
(fr)
|
1990-05-22 |
1992-07-31 |
Rhone Poulenc Sante |
Procede de preparation stereoselective de derives de la phenylisoserine.
|
US4997931A
(en)
|
1990-06-11 |
1991-03-05 |
Bristol-Myers Squibb Company |
Epipodophyllotoxin glycosides
|
GB9017024D0
(en)
|
1990-08-03 |
1990-09-19 |
Erba Carlo Spa |
New linker for bioactive agents
|
US5091368A
(en)
|
1990-08-08 |
1992-02-25 |
Harbor Branch Oceanographic Institution, Inc. |
Biologically active compounds from blue-green algae
|
WO1992005785A1
(en)
|
1990-09-28 |
1992-04-16 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogues, processes and methods
|
US5147294A
(en)
|
1990-10-01 |
1992-09-15 |
Trustees Of Boston University |
Therapeutic method for reducing chronic pain in a living subject
|
US5475120A
(en)
|
1990-11-02 |
1995-12-12 |
University Of Florida |
Method for the isolation and purification of taxol and its natural analogues
|
US5380916A
(en)
|
1990-11-02 |
1995-01-10 |
University Of Florida |
Method for the isolation and purification of taxane derivatives
|
JPH04185601A
(ja)
|
1990-11-20 |
1992-07-02 |
Unitika Ltd |
白金抗癌剤徐放性製剤
|
MX9102128A
(es)
|
1990-11-23 |
1992-07-08 |
Rhone Poulenc Rorer Sa |
Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
|
US5561136A
(en)
|
1990-12-13 |
1996-10-01 |
Merrell Pharmaceuticals Inc. |
Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
|
US5191082A
(en)
|
1990-12-20 |
1993-03-02 |
North Carolina State University |
Camptothecin intermediate and method of making camptothecin intermediates
|
US5200524A
(en)
|
1990-12-20 |
1993-04-06 |
North Carolina State University |
Camptothecin intermediates and method of making same
|
US5162532A
(en)
|
1990-12-20 |
1992-11-10 |
North Carolina State University |
Intermediates and method of making camptothecin and camptothecin analogs
|
US5272056A
(en)
|
1991-01-03 |
1993-12-21 |
The Research Foundation Of State University Of New York |
Modification of DNA and oligonucleotides using metal complexes of polyaza ligands
|
WO1992012132A1
(en)
|
1991-01-11 |
1992-07-23 |
Laboratoires Glaxo S.A. |
Acridine derivatives
|
US5684168A
(en)
|
1991-01-17 |
1997-11-04 |
Rhone-Poulenc Rorer S.A. |
β-phenylisoserine-(2R,3S), salts, preparation and use thereof
|
TW221441B
(zh)
|
1991-01-25 |
1994-03-01 |
Taiho Pharmaceutical Co Ltd |
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
CA2081343C
(fr)
|
1991-02-25 |
2003-09-16 |
Bruno Chauffert |
Agents therapeutiques pour le traitement de la resistance multi-drogue dans les cas de cancer
|
US5171217A
(en)
|
1991-02-28 |
1992-12-15 |
Indiana University Foundation |
Method for delivery of smooth muscle cell inhibitors
|
GB9105037D0
(en)
|
1991-03-09 |
1991-04-24 |
Johnson Matthey Plc |
Improvements in chemical compounds
|
US5194635A
(en)
|
1991-03-18 |
1993-03-16 |
Virginia Tech Intellectual Properties, Inc. |
Rearranged taxol compounds and method of using in testing of in vivo activity
|
HU220869B1
(en)
|
1991-03-23 |
2002-06-29 |
Sunkyong Ind Ltd |
Platinum(ii) complexes, pharmaceutical compositions comprising thereof and processes for preparing the same
|
WO1992018492A1
(en)
|
1991-04-19 |
1992-10-29 |
The University Of Mississippi |
Methods and compositions for isolating taxanes
|
IL101943A0
(en)
|
1991-05-24 |
1992-12-30 |
Genentech Inc |
Structure,production and use of heregulin
|
DK0590058T3
(da)
|
1991-06-14 |
2004-03-29 |
Genentech Inc |
Humaniseret heregulin-antistof
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
US5407653A
(en)
|
1991-06-26 |
1995-04-18 |
Brigham And Women's Hospital |
Evaluation of the multidrug resistance phenotype
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
SE9102074D0
(sv)
|
1991-07-03 |
1991-07-03 |
Kabi Pharmacia Ab |
Tomour antigen specific antibody
|
US5750561A
(en)
|
1991-07-08 |
1998-05-12 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
US5698582A
(en)
|
1991-07-08 |
1997-12-16 |
Rhone-Poulenc Rorer S.A. |
Compositions containing taxane derivatives
|
FR2678833B1
(fr)
|
1991-07-08 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
|
US5714512A
(en)
|
1991-07-08 |
1998-02-03 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
FR2678930B1
(fr)
|
1991-07-10 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
|
US5220016A
(en)
|
1991-07-29 |
1993-06-15 |
Board Of Regents, The University Of Texas System |
Synthesis of navelbine analogs
|
SG87056A1
(en)
|
1991-08-09 |
2002-03-19 |
Teikoku Hormone Mfg Co Ltd |
Novel tetrapeptide derivative
|
EP0656367A1
(en)
|
1991-08-22 |
1995-06-07 |
Becton, Dickinson and Company |
Method and composition for cancer therapy and for prognosticating responses to cancer theraphy
|
US5571153A
(en)
|
1991-09-20 |
1996-11-05 |
Wallst+E,Acu E+Ee N; Hans I. |
Device for hyperthermia treatment
|
US5399726A
(en)
|
1993-01-29 |
1995-03-21 |
Florida State University |
Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
|
US5338872A
(en)
|
1993-01-15 |
1994-08-16 |
Florida State University |
Process for the preparation of 10-desacetoxybaccatin III and 10-desacetoxytaxol and derivatives thereof
|
US6005138A
(en)
|
1991-09-23 |
1999-12-21 |
Florida State University |
Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US5728850A
(en)
|
1991-09-23 |
1998-03-17 |
Florida State University |
Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US5430160A
(en)
|
1991-09-23 |
1995-07-04 |
Florida State University |
Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
|
US5998656A
(en)
|
1991-09-23 |
1999-12-07 |
Florida State University |
C10 tricyclic taxanes
|
US6028205A
(en)
|
1991-09-23 |
2000-02-22 |
Florida State University |
C2 tricyclic taxanes
|
US5243045A
(en)
|
1991-09-23 |
1993-09-07 |
Florida State University |
Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
|
US5714513A
(en)
|
1991-09-23 |
1998-02-03 |
Florida State University |
C10 taxane derivatives and pharmaceutical compositions
|
US5654447A
(en)
|
1991-09-23 |
1997-08-05 |
Florida State University |
Process for the preparation of 10-desacetoxybaccatin III
|
US5350866A
(en)
|
1991-09-23 |
1994-09-27 |
Bristol-Myers Squibb Company |
10-desacetoxytaxol derivatives
|
US5710287A
(en)
|
1991-09-23 |
1998-01-20 |
Florida State University |
Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
|
US5721268A
(en)
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
US6018073A
(en)
|
1991-09-23 |
2000-01-25 |
Florida State University |
Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US5250683A
(en)
|
1991-09-23 |
1993-10-05 |
Florida State University |
Certain substituted taxanes and pharmaceutical compositions containing them
|
US5283253A
(en)
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
US5284864A
(en)
|
1991-09-23 |
1994-02-08 |
Florida State University |
Butenyl substituted taxanes and pharmaceutical compositions containing them
|
US6011056A
(en)
|
1991-09-23 |
2000-01-04 |
Florida State University |
C9 taxane derivatives and pharmaceutical compositions containing them
|
US5489601A
(en)
|
1991-09-23 |
1996-02-06 |
Florida State University |
Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
|
US5728725A
(en)
|
1991-09-23 |
1998-03-17 |
Florida State University |
C2 taxane derivaties and pharmaceutical compositions containing them
|
US5229526A
(en)
|
1991-09-23 |
1993-07-20 |
Florida State University |
Metal alkoxides
|
US5739362A
(en)
|
1991-09-23 |
1998-04-14 |
Florida State University |
Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US5274124A
(en)
|
1991-09-23 |
1993-12-28 |
Florida State University |
Metal alkoxides
|
US5227400A
(en)
|
1991-09-23 |
1993-07-13 |
Florida State University |
Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
|
FR2682110B1
(fr)
|
1991-10-02 |
1995-05-24 |
Atta |
Ligands amphiphiles perfluoroalkyles leurs complexes metalliques et leurs utilisations dans des preparations a usage therapeutique.
|
US6022541A
(en)
|
1991-10-18 |
2000-02-08 |
Beth Israel Deaconess Medical Center |
Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel
|
US5559235A
(en)
|
1991-10-29 |
1996-09-24 |
Glaxo Wellcome Inc. |
Water soluble camptothecin derivatives
|
US5344775A
(en)
|
1991-11-15 |
1994-09-06 |
Escagenetics Corporation |
Synthesis of taxanes in culture using pseudocalluscells
|
AU671605B2
(en)
|
1991-11-15 |
1996-09-05 |
Smithkline Beecham Corporation |
Combination chemotherapy
|
US5556609A
(en)
|
1992-02-20 |
1996-09-17 |
Rhomed Incorporated |
YIGSR peptide radiopharmaceutical applications
|
US5738838A
(en)
|
1992-02-20 |
1998-04-14 |
Rhomed Incorporated |
IKVAV peptide radiopharmaceutical applications
|
DE69329304T2
(de)
|
1992-01-15 |
2001-01-04 |
E.R. Squibb & Sons, Inc. |
Enzymatische Verfahren zur Resolution von Enantiomeren-Mischungen nützlich wie Zwischenprodukte zur Herstellung von Taxanen
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
EP0625200B1
(en)
|
1992-02-06 |
2005-05-11 |
Chiron Corporation |
Biosynthetic binding protein for cancer marker
|
FR2687145B1
(fr)
|
1992-02-07 |
1994-03-25 |
Rhone Poulenc Rorer Sa |
Nouveaux anhydrides d'acides, leur preparation et leur emplot et
|
US5407816A
(en)
|
1992-02-20 |
1995-04-18 |
Phyton Catalytic, Inc. |
Enhanced production of taxol and taxanes by cell cultures of taxus species
|
CA2131528C
(en)
|
1992-03-05 |
2004-07-13 |
Philip E. Thorpe |
Methods and compositions for targeting the vasculature of solid tumors
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US5660827A
(en)
|
1992-03-05 |
1997-08-26 |
Board Of Regents, The University Of Texas System |
Antibodies that bind to endoglin
|
IT1254515B
(it)
|
1992-03-06 |
1995-09-25 |
Indena Spa |
Tassani di interesse oncologico, loro metodo di preparazione ed uso
|
US5698712A
(en)
|
1992-03-06 |
1997-12-16 |
Indena S.P.A. |
Baccatine III derivatives
|
IT1254517B
(it)
|
1992-03-06 |
1995-09-25 |
Indena Spa |
14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
|
US5939561A
(en)
|
1992-03-10 |
1999-08-17 |
Rhone-Poulence Rorer S.A. |
Process for the preparation of β-phenylisoserine and β-lactam and their analogues
|
FR2688499B1
(fr)
|
1992-03-10 |
1994-05-06 |
Rhone Poulenc Rorer Sa |
Procede de preparation de la beta-phenylisoserine et de ses analogues.
|
US5200534A
(en)
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
CA2076465C
(en)
*
|
1992-03-25 |
2002-11-26 |
Ravi V. J. Chari |
Cell binding agent conjugates of analogues and derivatives of cc-1065
|
AU3939893A
(en)
|
1992-04-01 |
1993-11-08 |
Union Camp Corporation |
Induction of somatic embryogenesis in (taxus), and the production of taxane-ring containing alkaloids therefrom
|
US5850032A
(en)
|
1992-04-01 |
1998-12-15 |
Union Camp Corporation |
Method for production of plant biological products in precocious neomorphic embryoids
|
US5254703A
(en)
|
1992-04-06 |
1993-10-19 |
Florida State University |
Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones
|
CA2434692A1
(en)
|
1992-04-07 |
1993-10-08 |
Paul M. Cino |
Callus cell induction and the preparation of taxanes
|
AU4025193A
(en)
|
1992-04-08 |
1993-11-18 |
Cetus Oncology Corporation |
Humanized C-erbB-2 specific antibodies
|
US5622960A
(en)
|
1992-04-14 |
1997-04-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Topoisomerase II inhibitors and therapeutic uses therefor
|
US5322779A
(en)
|
1992-04-16 |
1994-06-21 |
The Research And Development Institute, Inc. At Montana State University |
Taxol production by taxomyces andreanae
|
US5831002A
(en)
|
1992-05-20 |
1998-11-03 |
Basf Aktiengesellschaft |
Antitumor peptides
|
US5237064A
(en)
|
1992-05-20 |
1993-08-17 |
Merck & Co., Inc. |
Process for producing 7β-substituted-aza-5αandrostan-3-ones
|
DE4317458A1
(de)
|
1992-06-11 |
1993-12-16 |
Bayer Ag |
Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
|
US5459269A
(en)
|
1992-06-18 |
1995-10-17 |
North Carolina State University |
14-halo-camptothecins
|
YU43193A
(sh)
|
1992-06-22 |
1997-01-08 |
Eli Lilly And Company |
2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
|
US5274137A
(en)
|
1992-06-23 |
1993-12-28 |
Nicolaou K C |
Intermediates for preparation of taxols
|
US5279953A
(en)
|
1992-06-24 |
1994-01-18 |
Esca Genetics Corporation |
In vivo production of taxanes
|
EP0655924A4
(en)
|
1992-06-30 |
1996-09-11 |
Oncologix Inc |
A COMBINATION OF MONOCLONAL ANTIBODIES AGAINST erbB-2 AND METHOD FOR THEIR USE.
|
US5364947A
(en)
|
1992-07-02 |
1994-11-15 |
Hauser Chemical Research, Inc. |
Process for separating cephalomannine from taxol using ozone and water-soluble hydrazines or hydrazides
|
US5792877A
(en)
|
1992-07-02 |
1998-08-11 |
Hauser Chemical Research, Inc. |
Girard derivatives of taxanes
|
US5334732A
(en)
|
1992-07-02 |
1994-08-02 |
Hauser Chemical Research, Inc. |
Oxidation of cephalomannine with ozone in the presence of taxol
|
US5354331A
(en)
|
1992-07-15 |
1994-10-11 |
Schachar Ronald A |
Treatment of presbyopia and other eye disorders
|
US5391745A
(en)
|
1992-07-23 |
1995-02-21 |
Sloan-Kettering Institute For Cancer Research |
Methods of preparation of camptothecin analogs
|
US5446047A
(en)
|
1992-07-23 |
1995-08-29 |
Sloan-Kettering Institute For Cancer Research |
Camptothecin analogues
|
IL102617A
(en)
|
1992-07-23 |
1996-01-19 |
Technion Res & Dev Foundation |
Method for Assessing Clinical Sensitivity and Multidrug Resistance to Mammalian Cell Anticancer Compounds
|
CA2086874E
(en)
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
US5202448A
(en)
|
1992-08-14 |
1993-04-13 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into baccatin III
|
US5256801A
(en)
|
1992-08-14 |
1993-10-26 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into 10-deacetylbaccatin III
|
US5470866A
(en)
|
1992-08-18 |
1995-11-28 |
Virginia Polytechnic Institute And State University |
Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
FR2696459B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2696458B1
(fr)
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2696464B1
(fr)
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
|
FR2696460B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2696454B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation stéréosélective d'un dérivé de la beta-phénylisosérine et son utilisation pour la préparation de dérivés du Taxane.
|
US5817321A
(en)
|
1992-10-08 |
1998-10-06 |
Supratek Pharma, Inc. |
Biological agent compositions
|
US5411984A
(en)
|
1992-10-16 |
1995-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble analogs and prodrugs of taxol
|
GB9222253D0
(en)
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
US5552156A
(en)
|
1992-10-23 |
1996-09-03 |
Ohio State University |
Liposomal and micellular stabilization of camptothecin drugs
|
US5891724A
(en)
|
1992-10-27 |
1999-04-06 |
Queen's University At Kingston |
Methods for conferring multidrug resistance on a cell
|
FR2697522B1
(fr)
|
1992-10-30 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
US5356928A
(en)
|
1992-11-06 |
1994-10-18 |
Hauser Chemical Research, Inc. |
Cytotoxic agents
|
US5412116A
(en)
|
1992-11-06 |
1995-05-02 |
Hauser Chemical Research, Inc. |
Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates
|
FR2697752B1
(fr)
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
US5420337A
(en)
|
1992-11-12 |
1995-05-30 |
E. R. Squibb & Sons, Inc. |
Enzymatic reduction method for the preparation of compounds useful for preparing taxanes
|
AP9300587A0
(en)
|
1992-11-12 |
1995-05-05 |
Glaxo Inc |
Water soluble camptothecin derivatives.
|
FR2698363B1
(fr)
|
1992-11-23 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.
|
US5281727A
(en)
|
1992-11-27 |
1994-01-25 |
Napro Biotherapeutics, Inc. |
Method of using ion exchange media to increase taxane yields
|
WO1994012268A1
(en)
|
1992-11-27 |
1994-06-09 |
Napro Biotherapeutics, Inc. |
Processing taxane solutes using membranes
|
FR2698543B1
(fr)
|
1992-12-02 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions à base de taxoides.
|
US6034065A
(en)
|
1992-12-03 |
2000-03-07 |
Arizona Board Of Regents |
Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
US5279949A
(en)
|
1992-12-07 |
1994-01-18 |
Board Of Trustees Operating Michigan State University |
Process for the isolation and purification of taxol and taxanes from Taxus spp
|
CA2126698A1
(en)
|
1992-12-07 |
1994-06-23 |
Muraleedharan G. Nair |
Process for the isolation and purification of taxol and taxanes from taxus spp.
|
US5814658A
(en)
|
1992-12-09 |
1998-09-29 |
Rhone-Poulenc Rorer S.A. |
Taxoids, their preparation and pharmaceutical compositions containing them
|
FR2698871B1
(fr)
|
1992-12-09 |
1995-02-24 |
Rhone Poulenc Rorer Sa |
Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
ATE196296T1
(de)
|
1992-12-16 |
2000-09-15 |
Basf Ag |
Dolastatin analog
|
FR2699535B1
(fr)
|
1992-12-22 |
1995-03-17 |
Pf Medicament |
Dérivés de l'étoposide, leur procédé de préparation, leur utilisation à titre de médicament et leur utilisation pour la préparation d'un médicament destiné au traitement anticancéreux.
|
US5973160A
(en)
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
GB9226830D0
(en)
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
US5622977A
(en)
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
US5646176A
(en)
|
1992-12-24 |
1997-07-08 |
Bristol-Myers Squibb Company |
Phosphonooxymethyl ethers of taxane derivatives
|
US5352804A
(en)
|
1993-01-19 |
1994-10-04 |
Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University |
Isolation and structure of Halistatin 2
|
US5410024A
(en)
|
1993-01-21 |
1995-04-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
BR9405687C1
(pt)
|
1993-02-05 |
2001-08-07 |
Bryn Mawr College |
Processo quìmico utilizável na produção de análogos de taxol e, composto quìmico
|
DE4305003A1
(de)
|
1993-02-18 |
1994-08-25 |
Knoll Ag |
Verfahren zur Herstellung kolloidaler wäßriger Lösungen schwer löslicher Wirkstoffe
|
US5527913A
(en)
|
1993-02-25 |
1996-06-18 |
The Stehlin Foundation For Cancer Research |
Methods for purifying camptothecin compounds
|
US5844001A
(en)
|
1993-02-26 |
1998-12-01 |
Research Development Foundation |
Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
|
US5604112A
(en)
|
1993-02-26 |
1997-02-18 |
The Dupont Merck Pharmaceutical Company |
Method for detecting the cardiotoxicity of compounds
|
US5756301A
(en)
|
1993-03-03 |
1998-05-26 |
The Trustees Of Columbia University In The City Of New York |
Endogenous taxol-like substance in human serum, monoclonal antibodies directed thereto and methods of assaying therefor
|
ES2193154T3
(es)
|
1993-03-05 |
2003-11-01 |
Univ Florida State |
Procedimiento para la preparacion de 9-desoxotaxanos.
|
US5547981A
(en)
|
1993-03-09 |
1996-08-20 |
Enzon, Inc. |
Taxol-7-carbazates
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
US5703247A
(en)
|
1993-03-11 |
1997-12-30 |
Virginia Tech Intellectual Properties, Inc. |
2-Debenzoyl-2-acyl taxol derivatives and methods for making same
|
US5475011A
(en)
|
1993-03-26 |
1995-12-12 |
The Research Foundation Of State University Of New York |
Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
|
US5824664A
(en)
|
1993-03-26 |
1998-10-20 |
U.S. Bioscience, Inc. |
Suppression of HIV expression by organic thiophosphate
|
FR2703353B1
(fr)
|
1993-03-29 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés de la beta-phénylisosérine.
|
WO1994022478A1
(en)
|
1993-03-30 |
1994-10-13 |
The Trustees Of The University Of Pennsylvania |
PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU)
|
US5482698A
(en)
|
1993-04-22 |
1996-01-09 |
Immunomedics, Inc. |
Detection and therapy of lesions with biotin/avidin polymer conjugates
|
US5336684A
(en)
|
1993-04-26 |
1994-08-09 |
Hauser Chemical Research, Inc. |
Oxidation products of cephalomannine
|
AU683893B2
(en)
|
1993-05-17 |
1997-11-27 |
Immunomedics Inc. |
Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
|
AU6833994A
(en)
|
1993-05-17 |
1994-12-12 |
Liposome Company, Inc., The |
Incorporation of taxol into liposomes and gels
|
IT1261667B
(it)
|
1993-05-20 |
1996-05-29 |
|
Tassano ad attivita' antitumorale.
|
US5380897A
(en)
|
1993-05-25 |
1995-01-10 |
Hoeschele; James D. |
Tri(platinum) complexes
|
US5405963A
(en)
|
1993-06-10 |
1995-04-11 |
Smithkline Beecham Corporation |
Process for asymmetric total synthesis of camptothecin analogues
|
ES2219968T3
(es)
|
1993-06-11 |
2004-12-01 |
PHARMACIA & UPJOHN COMPANY |
Uso antineoplasico de delta 6,7-taxoles y composiciones farmaceuticas que los contienen.
|
US5516676A
(en)
|
1993-06-15 |
1996-05-14 |
Bristol-Myers Squibb Company |
Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
|
US5523219A
(en)
|
1993-06-15 |
1996-06-04 |
Bristol-Myers Squibb Company |
Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
|
US5409690A
(en)
|
1993-06-23 |
1995-04-25 |
Chemex Pharmaceuticals, Inc. |
Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
|
US5744605A
(en)
|
1993-06-30 |
1998-04-28 |
University Of Pittsburgh |
Intermediates in the synthesis of (+) camptothecin and related compounds and synthesis thereof
|
TW397866B
(en)
|
1993-07-14 |
2000-07-11 |
Bristol Myers Squibb Co |
Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
|
US5716981A
(en)
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
US6005120A
(en)
|
1993-07-20 |
1999-12-21 |
Florida State University |
Tricyclic and tetracyclic taxanes
|
US5405972A
(en)
|
1993-07-20 |
1995-04-11 |
Florida State University |
Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
|
JP3161490B2
(ja)
|
1993-07-30 |
2001-04-25 |
松下電器産業株式会社 |
金型装置
|
US5455270A
(en)
|
1993-08-11 |
1995-10-03 |
Bristol-Myers Squibb Co. |
Stabilized solutions of platinum(II) antitumor agents
|
US5409677A
(en)
|
1993-08-26 |
1995-04-25 |
The Curators Of The University Of Missouri |
Process for separating a radionuclide from solution
|
US5475108A
(en)
|
1993-08-31 |
1995-12-12 |
North Carolina State University |
Camptothecin intermediates and method of making camptothecin and comptothecin analogs
|
US5409915A
(en)
|
1993-09-14 |
1995-04-25 |
The University Of Vermont And State Agricultural College |
Bis-platinum (IV) complexes as chemotherapeutic agents
|
US5498227A
(en)
|
1993-09-15 |
1996-03-12 |
Mawad; Michel E. |
Retrievable, shielded radiotherapy implant
|
US5484612A
(en)
|
1993-09-22 |
1996-01-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
|
GB9319944D0
(en)
|
1993-09-28 |
1993-11-17 |
Erba Carlo Spa |
Process for the preparation of 9-amino camptothecin
|
AU689131B2
(en)
|
1993-10-01 |
1998-03-26 |
Teikoku Hormone Mfg. Co., Ltd. |
Novel peptide derivative
|
US5648384A
(en)
|
1993-10-04 |
1997-07-15 |
Tanaka Kikinzoku Kogyo K.K. |
Anti-tumor platinum (IV) complex
|
GB9320781D0
(en)
|
1993-10-08 |
1993-12-01 |
Erba Carlo Spa |
Polymer-bound camptothecin derivatives
|
KR970010594B1
(ko)
|
1993-10-16 |
1997-06-28 |
한국과학기술연구원 |
말론산 유도체의 백금착화합물 및 그 제조방법
|
US5880131A
(en)
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
US5824701A
(en)
|
1993-10-20 |
1998-10-20 |
Enzon, Inc. |
Taxane-based prodrugs
|
US5840900A
(en)
|
1993-10-20 |
1998-11-24 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
CA2174350A1
(en)
|
1993-10-20 |
1995-04-27 |
Richard B. Greenwald |
2'- and/or 7- substituted taxoids
|
US5641627A
(en)
|
1993-10-25 |
1997-06-24 |
Ribogene, Inc. |
Methods for screening for antimycotics
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5459248A
(en)
|
1993-11-04 |
1995-10-17 |
Bristol-Myers Squibb Company |
Process of preparing etoposide phosphate and etoposide
|
US5633177A
(en)
|
1993-11-08 |
1997-05-27 |
Advanced Micro Devices, Inc. |
Method for producing a semiconductor gate conductor having an impurity migration barrier
|
US5415869A
(en)
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
US5821453A
(en)
|
1993-11-12 |
1998-10-13 |
The Ohio State University Research Foundation |
Molecular based magnets comprising vanadium tetracyanoethylene complexes for shielding electromagnetic fields
|
CA2153986C
(en)
|
1993-11-15 |
2002-12-31 |
Yukihito Yukimune |
A method of producing a taxane-type diterpene and method of obtaining cultured cells which produce the taxane-type diterpene at a high rate
|
US5436243A
(en)
|
1993-11-17 |
1995-07-25 |
Research Triangle Institute Duke University |
Aminoanthraquinone derivatives to combat multidrug resistance
|
US5855748A
(en)
|
1993-11-22 |
1999-01-05 |
E. I. Du Pont De Nemours And Company |
Electrochemical cell having a mass flow field made of glassy carbon
|
US6063911A
(en)
|
1993-12-01 |
2000-05-16 |
Marine Polymer Technologies, Inc. |
Methods and compositions for treatment of cell proliferative disorders
|
US5955423A
(en)
|
1993-12-21 |
1999-09-21 |
The University Of Hawaii |
Cryptophycins
|
DE69427706T2
(de)
|
1993-12-21 |
2001-10-25 |
University Of Hawaii, Honolulu |
Cryptophycine
|
US5952298A
(en)
|
1993-12-21 |
1999-09-14 |
The University Of Hawaii |
Cryptophycins
|
US5447936A
(en)
|
1993-12-22 |
1995-09-05 |
Bionumerik Pharmaceuticals, Inc. |
Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
|
ATE260911T1
(de)
|
1993-12-22 |
2004-03-15 |
Celltech R&D Ltd |
Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
GB9326173D0
(en)
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
US5476939A
(en)
|
1993-12-30 |
1995-12-19 |
Abbott Laboratories |
Certain pyridyl and isoquinolyl carbinolamine derivatives
|
IL112061A
(en)
|
1994-01-13 |
1999-10-28 |
Bristol Myers Squibb Co |
Methods for the preparation of taxanes
|
US5491285A
(en)
|
1994-01-21 |
1996-02-13 |
Goldsmith Seeds Inc. |
Phytophthora resistance gene of catharanthus and its use
|
IL127597A
(en)
|
1994-01-28 |
2003-07-31 |
Upjohn Co |
Iso-taxol analogs
|
AT400950B
(de)
|
1994-02-04 |
1996-04-25 |
Immodal Pharmaka Gmbh |
Verfahren zur technischen herstellung definierter isomerengemische aus verbindungen mit spirozyklischen - aminocarboxyl- und/oder spirozyklischen - aminocarbonyl-systemen
|
GB9402934D0
(en)
|
1994-02-16 |
1994-04-06 |
Erba Carlo Spa |
Camptothecin derivatives and process for their preparation
|
US5565478A
(en)
|
1994-03-14 |
1996-10-15 |
The United States Of America As Represented By The Department Of Health & Human Services |
Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
|
FR2718135B1
(fr)
|
1994-04-05 |
1996-04-26 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'hydroxy-7 taxanes.
|
US5449790A
(en)
|
1994-04-06 |
1995-09-12 |
Hauser Chemical Research, Inc. |
Preparation of 10-deacetylbaccatin III and 7-protected-10-deacetylbaccatin III derivatives from 10-deacetyl taxol A, 10-deacetyl taxol B, and 10-deacetyl taxol C
|
US5646011A
(en)
|
1994-04-08 |
1997-07-08 |
Yokoyama; Shiro |
Cisplatin resistance gene and uses therefor
|
DE4415263C1
(de)
|
1994-04-15 |
1995-11-30 |
Asta Medica Ag |
Cis-[trans-1,2-Cyclobutanbis(methylamin)-N,N']-[(2S)-lactato-O·1·, O·2·]-platin(II)-trihydrat (Lobaplatin-Trihydrat), seine Herstellung und arzneiliche Verwendung
|
US5468754A
(en)
|
1994-04-19 |
1995-11-21 |
Bionumerik Pharmaceuticals, Inc. |
11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
|
EP0704453A4
(en)
|
1994-04-19 |
1998-07-29 |
Toray Industries |
NEW PLATINUM (II) COMPLEX AND MEDICINE AGAINST MALIGNE TUMORS
|
GB9408218D0
(en)
|
1994-04-26 |
1994-06-15 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
US5604233A
(en)
|
1994-04-28 |
1997-02-18 |
Bionumerik Pharmaceuticals, Inc. |
Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
|
US5597829A
(en)
|
1994-05-09 |
1997-01-28 |
Bionumerik Pharmaceuticals, Inc. |
Lactone stable formulation of camptothecin and methods for uses thereof
|
US5882941A
(en)
|
1994-05-04 |
1999-03-16 |
Massachusette Institute Of Technology |
Programmable genotoxic agents and uses therefor
|
DE4415998A1
(de)
|
1994-05-06 |
1995-11-09 |
Basf Ag |
Neue Tetrapeptide, ihre Herstellung Verwendung
|
IT1269634B
(it)
|
1994-05-06 |
1997-04-08 |
Indena Spa |
Medicamento topico ad attivita' cicatrizzante
|
AU681036B2
(en)
|
1994-05-23 |
1997-08-14 |
B. Braun Medical, Inc. |
Formulation preparation device
|
US5508447A
(en)
|
1994-05-24 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Short synthetic route to taxol and taxol derivatives
|
GB9410388D0
(en)
|
1994-05-24 |
1994-07-13 |
Erba Carlo Spa |
Method for the preparation of 9-amino camptothecin
|
US5632982A
(en)
|
1994-06-07 |
1997-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cytotoxic enhancement of TNF with copper
|
US5605826A
(en)
|
1994-06-10 |
1997-02-25 |
Panorama Research, Inc. |
24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis
|
US5543152A
(en)
|
1994-06-20 |
1996-08-06 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
US5563132A
(en)
|
1994-06-21 |
1996-10-08 |
Bodaness; Richard S. |
Two-step cancer treatment method
|
US5602272A
(en)
|
1994-06-21 |
1997-02-11 |
Bristol-Myers Squibb Company |
Reduction and resolution methods for the preparation of compounds useful as intemediates for preparing taxanes
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412672D0
(en)
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
US5714163A
(en)
|
1994-06-27 |
1998-02-03 |
Nexstar Pharmaceuticals, Inc. |
Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
|
US5498738A
(en)
|
1994-06-28 |
1996-03-12 |
Karvinen; Esko |
Method for the preparation of a novel a-ring precursor for taxoids and novel intermediates
|
US5648505A
(en)
|
1994-06-28 |
1997-07-15 |
Xia; Zhi-Qiang |
Method for the preparation of a novel C-ring precursor for taxoids and novel intermediates
|
US5866679A
(en)
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
US5786344A
(en)
|
1994-07-05 |
1998-07-28 |
Arch Development Corporation |
Camptothecin drug combinations and methods with reduced side effects
|
US5864024A
(en)
|
1994-07-11 |
1999-01-26 |
Glinskii; Guennadi Victor |
Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis
|
US5629433A
(en)
|
1994-07-18 |
1997-05-13 |
Hauser, Inc. |
Selective process for the deacylation and deacetylation of taxol and taxanes
|
US5616330A
(en)
|
1994-07-19 |
1997-04-01 |
Hemagen/Pfc |
Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
|
US5547866A
(en)
|
1994-07-20 |
1996-08-20 |
The Regents Of The University Of California |
Taxane production in haploid-derived cell cultures
|
US5646159A
(en)
|
1994-07-20 |
1997-07-08 |
Research Triangle Institute |
Water-soluble esters of camptothecin compounds
|
US5561042A
(en)
|
1994-07-22 |
1996-10-01 |
Cancer Therapy And Research Center |
Diamine platinum naphthalimide complexes as antitumor agents
|
US5604095A
(en)
|
1994-07-22 |
1997-02-18 |
Cancer Therapy & Research Center |
Unsymmetrically linked bisnaphthalimides as antitumor agents
|
US5763477A
(en)
|
1994-07-22 |
1998-06-09 |
Dr. Reddy's Research Foundation |
Taxane derivatives from 14-β-hydroxy-10 deacetylbaccatin III
|
CA2195844C
(en)
|
1994-07-26 |
2001-10-09 |
Ezio Bombardelli |
Semi-synthetic taxanes with anti-tumoural activity
|
US5530097A
(en)
|
1994-08-01 |
1996-06-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory peptide amides
|
US5521284A
(en)
|
1994-08-01 |
1996-05-28 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides and esters
|
US5504191A
(en)
|
1994-08-01 |
1996-04-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide methyl esters
|
US5686578A
(en)
|
1994-08-05 |
1997-11-11 |
Immunomedics, Inc. |
Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
|
US5688773A
(en)
|
1994-08-17 |
1997-11-18 |
The General Hospital Corporation |
Method of selectively destroying neoplastic cells
|
AU694546C
(en)
|
1994-08-19 |
2001-09-06 |
La Region Wallonne |
Compounds, pharmaceutical composition and diagnostic device comprising same and their use
|
US5479648A
(en)
*
|
1994-08-30 |
1995-12-26 |
Stratus Computer, Inc. |
Method and apparatus for switching clock signals in a fault-tolerant computer system
|
JPH0873461A
(ja)
|
1994-09-06 |
1996-03-19 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体、その製造法および抗腫瘍剤
|
US5554725A
(en)
|
1994-09-14 |
1996-09-10 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Synthesis of dolastatin 15
|
US5763733A
(en)
|
1994-10-13 |
1998-06-09 |
Enzon, Inc. |
Antigen-binding fusion proteins
|
FR2725990B1
(fr)
|
1994-10-21 |
1997-01-10 |
Pf Medicament |
Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
|
JPH09509431A
(ja)
|
1994-11-04 |
1997-09-22 |
フアルマシア・エツセ・ピー・アー |
タキサン誘導体
|
DE4440193A1
(de)
|
1994-11-10 |
1996-05-15 |
Bayer Ag |
Verwendung von Dioxomorpholinen zur Bekämpfung von Endoparasiten, neue Dioxomorpholine und Verfahren zur ihrer Herstellung
|
US5599902A
(en)
|
1994-11-10 |
1997-02-04 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Cancer inhibitory peptides
|
US5789000A
(en)
|
1994-11-14 |
1998-08-04 |
Bionumerik Pharmaceuticals, Inc. |
Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
|
US5919816A
(en)
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
GB9422947D0
(en)
|
1994-11-14 |
1995-01-04 |
Univ Salamanca |
Immunosuppressive cyclolignan derivatives
|
CA2162086A1
(en)
|
1994-11-15 |
1996-05-16 |
Michihito Ise |
Agent for reducing nephrotoxicity due to medicine
|
US5783178A
(en)
|
1994-11-18 |
1998-07-21 |
Supratek Pharma. Inc. |
Polymer linked biological agents
|
RU2182598C2
(ru)
|
1994-11-21 |
2002-05-20 |
Новартис Аг |
Модифицированные ингибиторы протеиназы
|
US5679648A
(en)
*
|
1994-11-30 |
1997-10-21 |
The University Hospital |
Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
|
US5663149A
(en)
|
1994-12-13 |
1997-09-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
|
US5654328A
(en)
|
1994-12-15 |
1997-08-05 |
Sredni; Benjamin |
Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
|
US5597830A
(en)
|
1994-12-20 |
1997-01-28 |
Warner-Lambert Company |
Combination chemotherapy
|
GB9426090D0
(en)
|
1994-12-23 |
1995-02-22 |
Xenova Ltd |
Pharmaceutical compounds
|
US5580899A
(en)
|
1995-01-09 |
1996-12-03 |
The Liposome Company, Inc. |
Hydrophobic taxane derivatives
|
US5679807A
(en)
|
1995-01-30 |
1997-10-21 |
Hauser, Inc. |
Preparation of taxol and docetaxel through primary amines
|
US5496952A
(en)
|
1995-02-07 |
1996-03-05 |
North Carolina State University |
Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
|
GB9502799D0
(en)
|
1995-02-14 |
1995-04-05 |
Johnson Matthey Plc |
Improvements in platinum complexes
|
US5620875A
(en)
|
1995-02-17 |
1997-04-15 |
University Of Portland |
Transfer of taxol from yew tree cuttings into a culture medium over time
|
US5547982A
(en)
|
1995-02-27 |
1996-08-20 |
Johnson Matthey, Inc. |
Anti-tumor platinum complexes
|
JPH11501931A
(ja)
|
1995-03-10 |
1999-02-16 |
ハウザー,インコーポレイテッド |
セファロマンニンエポキシド、その類似体およびそれらの製造方法
|
IT1275936B1
(it)
|
1995-03-17 |
1997-10-24 |
Indena Spa |
Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
|
US5736156A
(en)
|
1995-03-22 |
1998-04-07 |
The Ohio State University |
Liposomal anf micellular stabilization of camptothecin drugs
|
CA2215833A1
(en)
|
1995-03-29 |
1996-10-03 |
Alan R. Ketring |
Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
|
US5855867A
(en)
|
1995-03-29 |
1999-01-05 |
The Curators Of The University Of Missouri |
Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
|
TW438775B
(en)
|
1995-04-07 |
2001-06-07 |
Pharmacia & Upjohn Co Llc |
Novel intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and related compounds
|
US5840929A
(en)
|
1995-04-14 |
1998-11-24 |
Bristol-Myers Squibb Company |
C4 methoxy ether derivatives of paclitaxel
|
DK0831100T3
(da)
|
1995-04-21 |
2001-01-02 |
Teikoku Hormone Mfg Co Ltd |
Nye peptidderivater
|
US5677286A
(en)
|
1995-04-27 |
1997-10-14 |
The University Of Michigan |
Glycosylated analogs of camptothecin
|
AU5516596A
(en)
|
1995-04-29 |
1996-11-21 |
Samyang Genex Co., Ltd. |
A method for mass production of taxol from taxus genus plant
|
US5834012A
(en)
|
1995-05-03 |
1998-11-10 |
Roman Perez-Soler |
Lipid complexed topoisomerase I inhibitors
|
US5561055A
(en)
|
1995-05-05 |
1996-10-01 |
Bcm Developpement Inc. |
Bacterial mass production of taxanes with Erwinia
|
US5807874A
(en)
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5767142A
(en)
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
GB9510716D0
(en)
|
1995-05-26 |
1995-07-19 |
Pharmacia Spa |
Substituted camptothecin derivatives and process for their preparation
|
US5670500A
(en)
|
1995-05-31 |
1997-09-23 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs
|
US5595878A
(en)
|
1995-06-02 |
1997-01-21 |
Boron Biologicals, Inc. |
Detection of biopolymers and biooligomers with boron hydride labels
|
US5935967A
(en)
|
1995-06-05 |
1999-08-10 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of highly lipophilic camptothecin derivatives
|
US5726181A
(en)
|
1995-06-05 |
1998-03-10 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and compositions of poorly water soluble camptothecin derivatives
|
US5972955A
(en)
|
1995-06-06 |
1999-10-26 |
Dr. Reddy's Research Foundation |
Water soluble C-ring analogues of 20(S)-camptothecin
|
AU706334B2
(en)
|
1995-06-06 |
1999-06-17 |
Pharm-Eco Laboratories, Inc. |
Stereoselective method for synthesizing dolaphenine
|
US5837234A
(en)
|
1995-06-07 |
1998-11-17 |
Cytotherapeutics, Inc. |
Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
|
US5780653A
(en)
|
1995-06-07 |
1998-07-14 |
Vivorx Pharmaceuticals, Inc. |
Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
|
US5716928A
(en)
|
1995-06-07 |
1998-02-10 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
EP0873363B1
(en)
|
1995-06-14 |
2010-10-06 |
The Regents of The University of California |
High affinity human antibodies to tumor antigens
|
GB9512471D0
(en)
|
1995-06-20 |
1995-08-23 |
Pharmacia Spa |
Method for the preparation of taxol and its derivatives
|
GB9512670D0
(en)
|
1995-06-21 |
1995-08-23 |
Sod Conseils Rech Applic |
Camptothecin analogues
|
CN102416176A
(zh)
|
1995-07-27 |
2012-04-18 |
基因技术股份有限公司 |
稳定等渗的冻干蛋白质制剂
|
DE19527575A1
(de)
|
1995-07-28 |
1997-01-30 |
Basf Ag |
Verfahren zur Herstellung von peptidischer Wirkstoffe
|
DE19527574A1
(de)
|
1995-07-28 |
1997-01-30 |
Basf Ag |
Verfahren zur Herstellung vona-(N,N-Dialkyl)-aminocaarbonsäureamiden
|
SG50747A1
(en)
|
1995-08-02 |
1998-07-20 |
Tanabe Seiyaku Co |
Comptothecin derivatives
|
US5760251A
(en)
|
1995-08-11 |
1998-06-02 |
Sepracor, Inc. |
Taxol process and compounds
|
WO1997008334A1
(en)
|
1995-08-30 |
1997-03-06 |
University Of Hawaii |
Cryptophycins from aberrant biosynthesis
|
US6107332A
(en)
|
1995-09-12 |
2000-08-22 |
The Liposome Company, Inc. |
Hydrolysis-promoting hydrophobic taxane derivatives
|
HU226325B1
(en)
|
1995-09-12 |
2008-08-28 |
Cephalon Ltd |
Hydrolysis-promoting hydrophobic taxane derivatives, medicaments comprising them and the use of medicaments
|
US6051600A
(en)
|
1995-09-12 |
2000-04-18 |
Mayhew; Eric |
Liposomal hydrolysis-promoting hydrophobic taxane derivatives
|
US5753507A
(en)
|
1995-09-22 |
1998-05-19 |
Novartis Finance Corporation |
Plant geraniol/nerol 10-hydroxylase and DNA coding therefor
|
KR0164460B1
(ko)
|
1995-10-02 |
1999-03-20 |
김은영 |
고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제
|
US5854278A
(en)
|
1995-12-13 |
1998-12-29 |
Xechem International, Inc. |
Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
|
US5807888A
(en)
|
1995-12-13 |
1998-09-15 |
Xechem International, Inc. |
Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
|
US5840748A
(en)
|
1995-10-02 |
1998-11-24 |
Xechem International, Inc. |
Dihalocephalomannine and methods of use therefor
|
US5654448A
(en)
|
1995-10-02 |
1997-08-05 |
Xechem International, Inc. |
Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
|
JP2907781B2
(ja)
|
1995-11-06 |
1999-06-21 |
エフ・ホフマン−ラ ロシユ アーゲー |
(4,5)−トランス−オキサゾリジンの新規製造法
|
US5807984A
(en)
|
1995-11-09 |
1998-09-15 |
Basf Aktienegesellschaft |
Oligopeptides, the preparation and use thereof
|
ATE218556T1
(de)
|
1995-11-17 |
2002-06-15 |
Biotechnolog Forschung Gmbh |
Epothilon-derivate und deren herstellung
|
US5849790A
(en)
|
1995-11-17 |
1998-12-15 |
The University Of South Florida |
(Mono) ethylenediaminenitroplatinum (IV) complexes with ligands of oxides of nitrogen as possible anti-tumor agents
|
AU7732996A
(en)
|
1995-11-22 |
1997-06-11 |
Research Triangle Institute |
Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
|
ES2191733T3
(es)
|
1995-12-04 |
2003-09-16 |
Nippon Kayaku Kk |
Procedimiento para producir etoposido.
|
US5783186A
(en)
|
1995-12-05 |
1998-07-21 |
Amgen Inc. |
Antibody-induced apoptosis
|
GB9526245D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526246D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
AU1469097A
(en)
|
1995-12-22 |
1997-07-17 |
Eli Lilly And Company |
Pharmaceutical compounds
|
CA2192725C
(en)
|
1995-12-28 |
2004-04-20 |
Kenji Tsujihara |
Camptothecin derivatives
|
GB9600438D0
(en)
|
1996-01-10 |
1996-03-13 |
Pharmacia Spa |
Hexacyclic camptothecin analogues, and process for preparing them
|
US5776925A
(en)
|
1996-01-25 |
1998-07-07 |
Pharmacyclics, Inc. |
Methods for cancer chemosensitization
|
GB9601779D0
(en)
|
1996-01-30 |
1996-04-03 |
Pharmacia Spa |
9, 10 Disubstituted camptothecin derivatives
|
US6096336A
(en)
|
1996-01-30 |
2000-08-01 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
US5731316A
(en)
|
1996-01-30 |
1998-03-24 |
The Stehlin Foundation For Cancer Research |
Derivatives of camptothecin and methods of treating cancer using these derivatives
|
US5670663A
(en)
|
1996-02-14 |
1997-09-23 |
Regents Of The University Of California |
Recovery of taxanes from conifers
|
AU2275697A
(en)
|
1996-02-21 |
1997-09-10 |
Matrix Pharmaceutical, Inc. |
Use of cell membrane permeants in the treatment of cellular proliferative disea ses
|
US5710099A
(en)
|
1996-02-27 |
1998-01-20 |
The United States Of America As Represented By The Secretary Of Agriculture |
Bioactive compounds
|
WO1997031632A1
(en)
|
1996-02-27 |
1997-09-04 |
Eli Lilly And Company |
Pharmaceutical compounds
|
PL189698B1
(pl)
|
1996-03-12 |
2005-09-30 |
Pg Txl Co |
Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
|
GB9608435D0
(en)
|
1996-04-24 |
1996-06-26 |
Celltech Therapeutics Ltd |
Chemical compounds
|
IT1283633B1
(it)
|
1996-05-10 |
1998-04-23 |
Indena Spa |
Derivati tassanici loro sintesi e formulazioni che li contengono
|
IT1283635B1
(it)
|
1996-05-10 |
1998-04-23 |
Indena Spa |
Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US5919815A
(en)
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
WO1997044407A1
(en)
|
1996-05-23 |
1997-11-27 |
Ian Alexander Gilmour |
Process for extraction of proanthocyanidins from botanical material
|
US5883120A
(en)
|
1997-06-16 |
1999-03-16 |
Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University |
Antifungal activity of the spongistatins
|
US5877205A
(en)
|
1996-06-28 |
1999-03-02 |
Board Of Regents, The University Of Texas System |
Parenteral paclitaxel in a stable non-toxic formulation
|
US5635531A
(en)
|
1996-07-08 |
1997-06-03 |
Bristol-Myers Squibb Company |
3'-aminocarbonyloxy paclitaxels
|
US5780446A
(en)
|
1996-07-09 |
1998-07-14 |
Baylor College Of Medicine |
Formulations of vesicant drugs and methods of use thereof
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
CN1097044C
(zh)
|
1996-07-15 |
2002-12-25 |
亚库尔特株式会社总社 |
紫杉烷衍生物以及含有该衍生物的药物
|
US5939527A
(en)
|
1996-07-30 |
1999-08-17 |
Basf Aktiengesellschaft |
Tetrapeptides as antitumor agents
|
US5741892A
(en)
|
1996-07-30 |
1998-04-21 |
Basf Aktiengesellschaft |
Pentapeptides as antitumor agents
|
WO1998007727A1
(en)
|
1996-08-19 |
1998-02-26 |
Bionumerik Pharmaceuticals, Inc. |
Highly lipophilic camptothecin derivatives
|
WO1998008833A1
(en)
|
1996-08-26 |
1998-03-05 |
Bristol-Myers Squibb Company |
Sulfenamide taxane derivatives
|
CA2264063C
(en)
|
1996-08-30 |
2007-03-13 |
Eli Lilly And Company |
Cryptophycin compounds
|
EP0923564A4
(en)
|
1996-08-30 |
1999-12-08 |
Lilly Co Eli |
PHARMACEUTICAL COMPOUNDS
|
NZ334821A
(en)
|
1996-08-30 |
2000-12-22 |
Novartis Ag |
Method for producing epothilones
|
WO1998008506A1
(en)
|
1996-08-30 |
1998-03-05 |
Eli Lilly And Company |
Pharmaceutical compounds
|
US5977387A
(en)
|
1996-08-30 |
1999-11-02 |
Eli Lilly And Company |
Process for preparing pharmaceutical compounds
|
US5969145A
(en)
|
1996-08-30 |
1999-10-19 |
Novartis Ag |
Process for the production of epothilones and intermediate products within the process
|
JP4849700B2
(ja)
*
|
1996-09-03 |
2012-01-11 |
中外製薬株式会社 |
抗インテグリンα3抗体の複合体
|
CA2264557A1
(en)
|
1996-09-06 |
1998-03-12 |
Eli Lilly And Company |
Process and novel intermediates
|
JP2001500128A
(ja)
|
1996-09-06 |
2001-01-09 |
イーライ・リリー・アンド・カンパニー |
薬用組成物を製造する方法
|
EP0956295A1
(en)
|
1996-09-06 |
1999-11-17 |
Eli Lilly And Company |
Process to prepare pharmaceutical compounds
|
WO1998009955A1
(en)
|
1996-09-06 |
1998-03-12 |
Eli Lilly And Company |
Process and novel intermediates
|
US20020052309A1
(en)
|
1996-09-11 |
2002-05-02 |
Athanasius A. Anagnostou |
Method of treating endothelial injury
|
US5773464A
(en)
|
1996-09-30 |
1998-06-30 |
Bristol-Myers Squibb Company |
C-10 epoxy taxanes
|
KR100628846B1
(ko)
|
1996-10-18 |
2006-09-29 |
제넨테크, 인크. |
항-ErbB2 항체
|
US5832931A
(en)
|
1996-10-30 |
1998-11-10 |
Photogen, Inc. |
Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
|
US5829448A
(en)
|
1996-10-30 |
1998-11-03 |
Photogen, Inc. |
Method for improved selectivity in photo-activation of molecular agents
|
NZ335383A
(en)
|
1996-11-18 |
2000-10-27 |
Biotechnolog Forschung Gmbh |
Epothilone C,D,E and F for plant protection and cytostatic effects shown in kidney cells
|
DE69734362T2
(de)
|
1996-12-03 |
2006-07-20 |
Sloan-Kettering Institute For Cancer Research |
Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
|
GB9625184D0
(en)
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US5843475A
(en)
|
1996-12-06 |
1998-12-01 |
Board Of Regents, The University Of Texas System |
Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
|
EP0944652B1
(en)
|
1996-12-12 |
2003-10-15 |
E.I. Du Pont De Nemours And Company |
Improved packaging composition
|
US6441186B1
(en)
|
1996-12-13 |
2002-08-27 |
The Scripps Research Institute |
Epothilone analogs
|
US5977386A
(en)
|
1996-12-24 |
1999-11-02 |
Bristol-Myers Squibb Company |
6-thio-substituted paclitaxels
|
US6077864A
(en)
|
1997-01-06 |
2000-06-20 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
US5833994A
(en)
|
1997-01-08 |
1998-11-10 |
Paracelsian, Inc. |
Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection
|
US5910102A
(en)
|
1997-01-10 |
1999-06-08 |
Scimed Life Systems, Inc. |
Conversion of beta radiation to gamma radiation for intravascular radiation therapy
|
US5739359A
(en)
|
1997-01-24 |
1998-04-14 |
Virginia Tech Intellectual Properties, Inc. |
Methods for preparing 1-deoxy paclitaxels
|
AU736062B2
(en)
|
1997-02-25 |
2001-07-26 |
Gesellschaft Fur Biotechnologische Forschung Mbh |
Epothilones which are modified in the side chain
|
CA2281104A1
(en)
|
1997-02-26 |
1998-09-03 |
University Of Hawaii |
Selective epoxidation process for preparing pharmaceutical compounds
|
AU6338698A
(en)
|
1997-02-26 |
1998-09-18 |
Eli Lilly And Company |
Tripeptide and tetrapeptide pharmaceutical compounds
|
US5902822A
(en)
|
1997-02-28 |
1999-05-11 |
Bristol-Myers Squibb Company |
7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
|
US5912264A
(en)
|
1997-03-03 |
1999-06-15 |
Bristol-Myers Squibb Company |
6-halo-or nitrate-substituted paclitaxels
|
US5886025A
(en)
|
1997-03-06 |
1999-03-23 |
Baylor University |
Anti-mitotic agents which inhibit tubulin polymerization
|
US5994367A
(en)
|
1997-03-07 |
1999-11-30 |
The University Of North Carolina At Chapel Hill |
Method for treating tumors using 2-aryl-naphthyridin-4-ones
|
US5965537A
(en)
|
1997-03-10 |
1999-10-12 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
|
US5939455A
(en)
|
1997-03-11 |
1999-08-17 |
Beacon Laboratories, Inc. |
Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives
|
GB9705035D0
(en)
|
1997-03-11 |
1997-04-30 |
Pharmacia & Upjohn Spa |
Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
|
US6103698A
(en)
|
1997-03-13 |
2000-08-15 |
Basf Aktiengesellschaft |
Dolastatin-15 derivatives in combination with taxanes
|
US5843993A
(en)
|
1997-03-14 |
1998-12-01 |
The Curators Of The University Of Missouri |
Hydroxyalkyl phosphine gold complexes for use as diagnostic and therapeutic pharmaceuticals and method of making same
|
EP0870510A3
(en)
|
1997-04-11 |
1999-09-15 |
Eli Lilly And Company |
Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents
|
EP0870501A1
(en)
|
1997-04-11 |
1998-10-14 |
Eli Lilly And Company |
Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
|
EP0870506A1
(en)
|
1997-04-11 |
1998-10-14 |
Eli Lilly And Company |
Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
|
US6017935A
(en)
|
1997-04-24 |
2000-01-25 |
Bristol-Myers Squibb Company |
7-sulfur substituted paclitaxels
|
US6117659A
(en)
|
1997-04-30 |
2000-09-12 |
Kosan Biosciences, Inc. |
Recombinant narbonolide polyketide synthase
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
US6046209A
(en)
|
1997-05-27 |
2000-04-04 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs
|
US5919126A
(en)
|
1997-07-07 |
1999-07-06 |
Implant Sciences Corporation |
Coronary stent with a radioactive, radiopaque coating
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
DE59805727D1
(de)
|
1997-07-16 |
2002-10-31 |
Schering Ag |
Thiazolderivate, verfahren zur herstellung und verwendung
|
GB9715821D0
(en)
|
1997-07-25 |
1997-10-01 |
Pharmacia & Upjohn Spa |
Amidino-camptothecin derivatives
|
US5922877A
(en)
|
1997-08-05 |
1999-07-13 |
The Stehlin Foundation For Cancer Research |
Methods of preparing and purifying 9-nitro-20-camptothecin
|
DK1005465T3
(da)
|
1997-08-09 |
2007-11-05 |
Bayer Schering Pharma Ag |
Nye epothilon-derivater, fremgangsmåde til fremstilling heraf og deres farmaceutiske anvendelse
|
US6121278A
(en)
|
1997-09-03 |
2000-09-19 |
Guilford Pharmaceuticals, Inc. |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
|
US6120800A
(en)
|
1997-09-25 |
2000-09-19 |
Nexstar Pharmaceuticals, Inc. |
Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
|
US5917062A
(en)
|
1997-11-21 |
1999-06-29 |
Indena S.P.A |
Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
|
US6365749B1
(en)
|
1997-12-04 |
2002-04-02 |
Bristol-Myers Squibb Company |
Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
|
EP1042327B1
(en)
|
1997-12-04 |
2003-09-17 |
Bristol-Myers Squibb Company |
A process for the reduction of oxiranyl epothilones to olefinic epothilones
|
US6020495A
(en)
|
1997-12-08 |
2000-02-01 |
Pharm-Eco Laboratories, Inc. |
Stereoselective method for synthesizing dolaphenine
|
ZA9811162B
(en)
|
1997-12-12 |
2000-06-07 |
Genentech Inc |
Treatment with anti-ERBB2 antibodies.
|
US6030818A
(en)
|
1997-12-22 |
2000-02-29 |
Bcm Developpement, Inc. |
Bacterial mass production of taxanes and paclitaxel
|
US6096757A
(en)
|
1998-12-21 |
2000-08-01 |
Schering Corporation |
Method for treating proliferative diseases
|
KR100246722B1
(ko)
|
1997-12-30 |
2000-04-01 |
박호군 |
경구용 백금 착화합물 항암제 및 그 제조방법
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
US6017890A
(en)
|
1998-02-19 |
2000-01-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
Azole peptidomimetics as thrombin receptor antagonists
|
US6069146A
(en)
|
1998-03-25 |
2000-05-30 |
The Regents Of The University Of California |
Halimide, a cytotoxic marine natural product, and derivatives thereof
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
US6066749A
(en)
|
1998-05-01 |
2000-05-23 |
Napro Biotherapeutics, Inc. |
Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis
|
US6048990A
(en)
|
1998-05-01 |
2000-04-11 |
Napro Biotherapeutics, Inc. |
Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
|
US6121029A
(en)
|
1998-06-18 |
2000-09-19 |
Novartis Ag |
Genes for the biosynthesis of epothilones
|
US5981564A
(en)
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
US5985837A
(en)
|
1998-07-08 |
1999-11-16 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
WO2000020579A1
(en)
|
1998-10-02 |
2000-04-13 |
Mcmaster University |
Spliced form of erbb-2/neu oncogene
|
US6025516A
(en)
|
1998-10-14 |
2000-02-15 |
Chiragene, Inc. |
Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
|
US6103913A
(en)
|
1998-10-16 |
2000-08-15 |
Eli Lilly And Company |
Process for preparing enollactone derivatives
|
US6040330A
(en)
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
DK2266537T3
(en)
|
1999-04-01 |
2014-12-15 |
Talon Therapeutics Inc |
Compositions for treating cancer
|
JP4926320B2
(ja)
|
1999-04-28 |
2012-05-09 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
Vegfの選択的阻害による癌処置のための組成物および方法
|
AU782325B2
(en)
|
1999-05-14 |
2005-07-21 |
Genentech Inc. |
Treatment with anti-ErbB2 antibodies
|
US20040013667A1
(en)
|
1999-06-25 |
2004-01-22 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
ATE437655T1
(de)
|
1999-06-25 |
2009-08-15 |
Genentech Inc |
Humanisierte anti-erbb2 antikörper und behandlung mit anti-erbb2 antikörper
|
US20030086924A1
(en)
|
1999-06-25 |
2003-05-08 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
JP4579471B2
(ja)
|
1999-06-25 |
2010-11-10 |
ジェネンテック, インコーポレイテッド |
抗ErbB2抗体を用いる前立腺癌の処置
|
HU230586B1
(hu)
*
|
1999-06-25 |
2017-02-28 |
Genentech, Inc. |
Anti-ErbB antitest/maytansinoid konjugátumok alkalmazása rákos betegségek kezelésére szolgáló gyógyszer előállítására
|
US6362342B1
(en)
|
1999-06-29 |
2002-03-26 |
Lion Bioscience Ag |
Triazole compounds and methods of making same
|
US6531131B1
(en)
|
1999-08-10 |
2003-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugate vaccine for Neisseria meningitidis
|
US6114365A
(en)
|
1999-08-12 |
2000-09-05 |
Pharmacia & Upjohn S.P.A. |
Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
|
US6635677B2
(en)
|
1999-08-13 |
2003-10-21 |
Case Western Reserve University |
Methoxyamine combinations in the treatment of cancer
|
KR20090024308A
(ko)
|
1999-08-27 |
2009-03-06 |
제넨테크, 인크. |
항-ErbB2 항체 투여 치료 방법
|
US7030231B1
(en)
|
1999-09-30 |
2006-04-18 |
Catalyst Biosciences, Inc. |
Membrane type serine protease 1 (MT-SP1) and uses thereof
|
CA2385528C
(en)
|
1999-10-01 |
2013-12-10 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
US7303749B1
(en)
|
1999-10-01 |
2007-12-04 |
Immunogen Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
JP2003514903A
(ja)
*
|
1999-11-24 |
2003-04-22 |
イムノージェン インコーポレーテッド |
タキサンを含有する細胞傷害薬とその治療への利用
|
US6632979B2
(en)
|
2000-03-16 |
2003-10-14 |
Genentech, Inc. |
Rodent HER2 tumor model
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
US6333410B1
(en)
|
2000-08-18 |
2001-12-25 |
Immunogen, Inc. |
Process for the preparation and purification of thiol-containing maytansinoids
|
JP2004520806A
(ja)
|
2000-08-24 |
2004-07-15 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
KR100607612B1
(ko)
|
2001-06-20 |
2006-08-02 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
US20080085283A1
(en)
|
2001-09-05 |
2008-04-10 |
Levinson Arthur D |
Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
|
US20040235068A1
(en)
|
2001-09-05 |
2004-11-25 |
Levinson Arthur D. |
Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
|
EP2153843B1
(en)
|
2001-09-18 |
2012-08-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US20050238650A1
(en)
|
2002-04-17 |
2005-10-27 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
AU2003247762B2
(en)
|
2002-07-03 |
2008-05-01 |
Immunogen, Inc. |
Antibodies to non-shed MUC1 and MUC16, and uses thereof
|
AU2003259913A1
(en)
|
2002-08-19 |
2004-03-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
KR101441358B1
(ko)
|
2003-05-14 |
2014-09-24 |
이뮤노젠 아이엔씨 |
약물 콘쥬게이트 조성물
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
US7754441B2
(en)
|
2003-11-17 |
2010-07-13 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
JP3991983B2
(ja)
|
2003-12-19 |
2007-10-17 |
日産自動車株式会社 |
車両の駆動制御装置
|
JP4658967B2
(ja)
|
2003-12-24 |
2011-03-23 |
ジェネンテック, インコーポレイテッド |
造血系起源の腫瘍の治療のための組成物と方法
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
BRPI0510883B8
(pt)
|
2004-06-01 |
2021-05-25 |
Genentech Inc |
composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|